RxNorm Semantic Concepts Index - 260
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "260".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 26000 | Glycerophosphocholine phosphodiesterase | Designated preferred name (PT) | NO | |
RxCUI: 26000 | Glycerophosphocholine phosphodiesterase | Full form of descriptor (FN) | NO | |
RxCUI: 2600001 | cefadroxil Oral Suspension [Ultracef] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 260001 | folic acid 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260001 | folic acid 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260001 | folic acid 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260002 | folic acid 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260002 | folic acid 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260002 | folic acid 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600046 | diclofenac / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2600047 | diclofenac / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2600048 | diclofenac / lidocaine Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600050 | Bacillus clausii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 260006 | urea 10 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260006 | urea 10 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260006 | urea 10 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Designated preferred name (PT) | NO | |
RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Full form of descriptor (FN) | NO | |
RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260012 | willow bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260012 | willow bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260012 | willow bark extract | Designated preferred name (PT) | YES | |
RxCUI: 260012 | willow bark extract | Full form of descriptor (FN) | YES | |
RxCUI: 260012 | willow bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260014 | watermelon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 260020 | horse chestnut seed | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260025 | Brauneria purpurea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260025 | Brauneria purpurea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260025 | Brauneria purpurea extract | Designated preferred name (PT) | YES | |
RxCUI: 260025 | Brauneria purpurea extract | Full form of descriptor (FN) | YES | |
RxCUI: 260025 | Brauneria purpurea extract | Full form of descriptor (FN) | YES | |
RxCUI: 260025 | Brauneria purpurea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600295 | amantadine 161 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2600296 | amantadine 161 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600296 | amantadine 161 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600297 | amantadine 161 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600297 | amantadine 161 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600298 | amantadine 161 MG [Osmolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600348 | sodium chloride 9 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600351 | calcium fructoborate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 260036 | Cevimeline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 260036 | Cevimeline hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 260036 | Cevimeline hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 260038 | Korean ginseng root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260039 | sangre de grado | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 260039 | sangre de grado | Designated preferred name (PT) | NO | |
RxCUI: 260039 | sangre de grado | Full form of descriptor (FN) | NO | |
RxCUI: 260040 | Oenothera biennis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260040 | Oenothera biennis whole extract | Designated preferred name (PT) | YES | |
RxCUI: 260040 | Oenothera biennis whole extract | Full form of descriptor (FN) | YES | |
RxCUI: 260040 | Oenothera biennis whole extract | Designated preferred name (PT) | YES | |
RxCUI: 260040 | Oenothera biennis whole extract | Full form of descriptor (FN) | YES | |
RxCUI: 260040 | Oenothera biennis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260051 | wasp venom protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260053 | elderberry fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260055 | kava root 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260063 | guaifenesin 200 MG / theophylline 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260063 | guaifenesin 200 MG / theophylline 150 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260066 | methylcellulose 133.3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Designated preferred name (PT) | NO | |
RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Full form of descriptor (FN) | NO | |
RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Designated preferred name (PT) | NO | |
RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Full form of descriptor (FN) | NO | |
RxCUI: 260076 | calcium phosphate 250 MG / gamboge 115 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260077 | ginger root 470 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600775 | bismuth phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2600776 | cadmium fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2600777 | isomaltitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2600779 | imepitoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2600781 | magnesium carbonate 10.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600783 | Magonate Reformulated May 2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2600784 | magnesium carbonate 10.8 MG/ML [Magonate Reformulated May 2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600785 | Magonate Reformulated May 2022 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2600786 | Magonate Reformulated May 2022 Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2600787 | magnesium carbonate Oral Solution [Magonate Reformulated May 2022] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260080 | calcium carbonate 265 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260084 | horse chestnut seed 300 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260084 | horse chestnut seed 300 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260086 | melatonin 3 MG / pyridoxine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260086 | melatonin 3 MG / pyridoxine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600867 | mavacamten | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2600868 | mavacamten 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2600869 | mavacamten Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2600870 | mavacamten Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2600871 | mavacamten Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2600872 | mavacamten 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600872 | mavacamten 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600873 | Camzyos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2600874 | mavacamten 10 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600875 | Camzyos Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2600876 | Camzyos Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2600877 | mavacamten Oral Capsule [Camzyos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600879 | mavacamten 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 260088 | carbetapentane tannate 12 MG / chlorpheniramine tannate 1.6 MG/ML / phenylephrine tannate 2 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600880 | mavacamten 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600880 | mavacamten 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600881 | mavacamten 15 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600883 | mavacamten 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2600884 | mavacamten 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600884 | mavacamten 2.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600885 | mavacamten 2.5 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600887 | mavacamten 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2600888 | mavacamten 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600888 | mavacamten 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2600889 | mavacamten 5 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600910 | camphor 6 % / menthol 4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600910 | camphor 6 % / menthol 4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600915 | potassium citrate 0.0553 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2600916 | sodium fluoride 0.0032 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2600917 | potassium citrate / sodium fluoride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2600918 | potassium citrate / sodium fluoride Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2600919 | potassium citrate / sodium fluoride Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 260092 | sangre de grado 350 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260092 | sangre de grado 350 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600920 | potassium citrate / sodium fluoride Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2600921 | potassium citrate / sodium fluoride Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2600922 | potassium citrate / sodium fluoride Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600924 | sodium chloride 10.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2600926 | sodium chloride 10.5 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2600965 | Epsolay | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2600966 | benzoyl peroxide 50 MG/ML [Epsolay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2600967 | Epsolay Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2600968 | benzoyl peroxide Topical Cream [Epsolay] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601 | clonixin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Designated preferred name (PT) | NO | |
RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Full form of descriptor (FN) | NO | |
RxCUI: 260101 | Oseltamivir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260101 | Oseltamivir | Designated preferred name (PT) | YES | |
RxCUI: 260101 | Oseltamivir | Full form of descriptor (FN) | YES | |
RxCUI: 260101 | Oseltamivir | Designated preferred name (PT) | YES | |
RxCUI: 260101 | Oseltamivir | Full form of descriptor (FN) | YES | |
RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601098 | Commiphora wightii resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601099 | Gaultheria procumbens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601100 | PEG-6 sorbitan stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601101 | Triluron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2601102 | sodium hyaluronate 10 MG/ML [Triluron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601103 | Triluron Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601104 | hyaluronate Prefilled Syringe [Triluron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601108 | trachyspermum ammi flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601109 | Vitex negundo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601115 | dexmedetomidine 0.12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601115 | dexmedetomidine 0.12 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601116 | dexmedetomidine Sublingual Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2601116 | dexmedetomidine Sublingual Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601117 | dexmedetomidine Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2601117 | dexmedetomidine Oral Film Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601118 | dexmedetomidine Sublingual Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2601118 | dexmedetomidine Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601120 | Igalmi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2601121 | dexmedetomidine 0.12 MG [Igalmi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601121 | dexmedetomidine 0.12 MG [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601122 | Igalmi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601123 | Igalmi Sublingual Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601124 | Igalmi Oral Film Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601125 | dexmedetomidine Sublingual Film [Igalmi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2601125 | dexmedetomidine Sublingual Film [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601128 | dexmedetomidine 0.18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601128 | dexmedetomidine 0.18 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601130 | dexmedetomidine 0.18 MG [Igalmi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601130 | dexmedetomidine 0.18 MG [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260117 | chitosan 500 MG / chromium picolinate 0.05 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260121 | kava root 233 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260121 | kava root 233 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260122 | diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260123 | Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Designated preferred name (PT) | NO | |
RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Full form of descriptor (FN) | NO | |
RxCUI: 260127 | prednisolone 50 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260127 | prednisolone 50 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2601304 | frunevetmab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601307 | cholecalciferol 0.0625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601368 | petrolatum 0.934 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601369 | petrolatum 93.4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601369 | petrolatum 93.4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601447 | calcium bromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601450 | menthol 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601450 | menthol 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601450 | menthol 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601502 | Azaperone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601502 | Azaperone | Designated preferred name (PT) | NO | |
RxCUI: 2601502 | Azaperone | Full form of descriptor (FN) | NO | |
RxCUI: 2601503 | hypromellose 2910 0.45% stearoxy ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601541 | bortezomib 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601542 | bortezomib 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601542 | bortezomib 1 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601543 | bortezomib 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601544 | bortezomib 2.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601544 | bortezomib 2.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601548 | Spikevax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2601549 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML [Spikevax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601550 | Spikevax Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601551 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Spikevax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601578 | epinephrine / lidocaine Rectal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2601578 | epinephrine / lidocaine Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2601580 | menthol 27.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601581 | menthol 2.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601581 | menthol 2.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601581 | menthol 2.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601582 | medetomidine hydrochloride 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601583 | vatinoxan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2601584 | vatinoxan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601585 | vatinoxan hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601586 | medetomidine / vatinoxan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2601587 | medetomidine / vatinoxan Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2601588 | medetomidine / vatinoxan Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2601589 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601589 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601590 | Zenalpha | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2601591 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML [Zenalpha] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2601592 | Zenalpha Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2601593 | medetomidine / vatinoxan Injectable Solution [Zenalpha] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601595 | disodium glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2601715 | Phyllostachys nigra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2601717 | zinc gluconate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2601718 | zinc gluconate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2601719 | zinc gluconate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601721 | water 970 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601723 | tirzepatide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2601724 | baricitinib 4 MG [Olumiant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601727 | pemetrexed 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601727 | pemetrexed 1000 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2601730 | tirzepatide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2601731 | tirzepatide Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2601734 | Mounjaro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2601736 | Mounjaro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2601737 | tirzepatide Auto-Injector [Mounjaro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2601740 | zinc pyrithione 2.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601742 | tirzepatide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601744 | tirzepatide 10 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601745 | tirzepatide 10 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601747 | tirzepatide 10 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601747 | tirzepatide 10 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601754 | tirzepatide 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601756 | tirzepatide 30 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601757 | tirzepatide 30 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601759 | tirzepatide 30 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601759 | tirzepatide 30 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601760 | tirzepatide 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601762 | tirzepatide 5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601763 | tirzepatide 5 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601765 | tirzepatide 5 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601765 | tirzepatide 5 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601766 | tirzepatide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601768 | tirzepatide 20 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601769 | tirzepatide 20 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601771 | tirzepatide 20 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601771 | tirzepatide 20 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601772 | tirzepatide 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601774 | tirzepatide 25 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601775 | tirzepatide 25 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601777 | tirzepatide 25 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601777 | tirzepatide 25 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601778 | tirzepatide 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2601780 | tirzepatide 15 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601781 | tirzepatide 15 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2601783 | tirzepatide 15 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601783 | tirzepatide 15 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2601786 | frunevetmab 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2601787 | frunevetmab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2601788 | frunevetmab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601790 | frunevetmab 7 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2601791 | Solensia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2601792 | frunevetmab 7 MG/ML [Solensia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2601793 | Solensia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2601794 | frunevetmab Injection [Solensia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2601796 | frunevetmab 7 MG/ML Injection [Solensia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2601796 | frunevetmab 7 MG/ML Injection [Solensia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260208 | Haemophilus capsular oligosaccharide 0.03 MG/ML / Neisseria meningitidis 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260209 | Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 26021 | Glycine acetyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 26021 | Glycine acetyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 2602113 | edaravone 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602114 | edaravone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2602115 | edaravone Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2602116 | edaravone Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602118 | edaravone 21 MG/ML [Radicava] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602119 | Radicava Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602120 | Radicava Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602121 | edaravone Oral Suspension [Radicava] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602123 | tecovirimat 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602124 | tecovirimat Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2602125 | tecovirimat Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602127 | tecovirimat 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2602127 | tecovirimat 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602128 | tecovirimat 10 MG/ML [Tpoxx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602129 | Tpoxx Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602130 | tecovirimat Injection [Tpoxx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602133 | ethyl glycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602134 | iscotrizinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602135 | pemetrexed 750 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602135 | pemetrexed 750 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602137 | zinc gluconate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602140 | Allday | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602141 | sodium fluoride 0.011 MG/MG [Allday] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602142 | Allday Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602143 | Allday Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602144 | Allday Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602145 | Allday Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602146 | sodium fluoride Toothpaste [Allday] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260218 | modafinil 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260218 | modafinil 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 260218 | modafinil 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260218 | modafinil 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 26022 | Glycine acyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 26022 | Glycine acyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 260223 | hydroquinone 4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260223 | hydroquinone 4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260223 | hydroquinone 4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260225 | stannous fluoride 11 MG/mL Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260225 | stannous fluoride 11 MG/mL Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602275 | brolucizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602277 | brolucizumab-dbll 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602278 | brolucizumab Prefilled Syringe [Beovu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602280 | brolucizumab-dbll 120 MG/ML Prefilled Syringe [Beovu] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602280 | brolucizumab-dbll 120 MG/ML Prefilled Syringe [Beovu] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2602282 | ceteth-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602283 | Echinacea purpurea flowering top water | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602284 | butyloctanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602285 | solanum anomalum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602286 | tapinarof | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2602288 | Differin Acne Clearing | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602289 | salicylic acid 20 MG/ML [Differin Acne Clearing] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 260229 | clotrimazole 1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260229 | clotrimazole 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260229 | clotrimazole 1 % Topical Powder | Designated preferred name (PT) | NO | |
RxCUI: 260229 | clotrimazole 1 % Topical Powder | Full form of descriptor (FN) | NO | |
RxCUI: 2602290 | Differin Acne Clearing Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602291 | salicylic acid Medicated Liquid Soap [Differin Acne Clearing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602293 | Differin Acne Clearing Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602294 | salicylic acid Topical Spray [Differin Acne Clearing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602298 | tapinarof 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602299 | tapinarof Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2602300 | tapinarof Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602301 | tapinarof 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602301 | tapinarof 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602302 | Vtama | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602303 | tapinarof 10 MG/ML [Vtama] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602304 | Vtama Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602305 | tapinarof Topical Cream [Vtama] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602306 | Vtama 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602306 | Vtama 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602306 | Vtama 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260231 | dimethyl sulfoxide 1000 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260235 | iron carbonyl (as iron) 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260235 | iron carbonyl (as iron) 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602351 | ranibizumab-nuna | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2602352 | ranibizumab-nuna 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602354 | ranibizumab-nuna 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602355 | Byooviz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602356 | ranibizumab-nuna 10 MG/ML [Byooviz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602357 | Byooviz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602358 | ranibizumab Injection [Byooviz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602360 | ranibizumab-nuna 10 MG/ML Injection [Byooviz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602360 | ranibizumab-nuna 10 MG/ML Injection [Byooviz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602364 | pemetrexed 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602364 | pemetrexed 25 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 26024 | Glycine amidinotransferase | Designated preferred name (PT) | NO | |
RxCUI: 26024 | Glycine amidinotransferase | Full form of descriptor (FN) | NO | |
RxCUI: 260243 | progesterone 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 260243 | progesterone 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260243 | progesterone 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 260243 | progesterone 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260246 | levobupivacaine 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260247 | levobupivacaine 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260248 | levobupivacaine 0.75 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 26025 | Glycine aminotransferase | Designated preferred name (PT) | NO | |
RxCUI: 26025 | Glycine aminotransferase | Full form of descriptor (FN) | NO | |
RxCUI: 260256 | rapacuronium 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602563 | acetylcysteine 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2602564 | acetylcysteine 1.2 GM Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2602564 | acetylcysteine 1.2 GM Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602577 | oteseconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2602578 | oteseconazole 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602579 | oteseconazole Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 260258 | dextrose 250 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260258 | dextrose 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602580 | oteseconazole Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2602581 | oteseconazole Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602582 | oteseconazole 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602582 | oteseconazole 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602583 | Vivjoa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602584 | oteseconazole 150 MG [Vivjoa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602585 | Vivjoa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602586 | Vivjoa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602587 | oteseconazole Oral Capsule [Vivjoa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 26026 | Glycine dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 26026 | Glycine dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Designated preferred name (PT) | YES | |
RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 260269 | benzocaine 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260269 | benzocaine 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260269 | benzocaine 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602749 | treprostinil 0.016 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602750 | treprostinil Inhalation Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602752 | treprostinil 0.016 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602753 | treprostinil Inhalation Powder [Tyvaso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602755 | treprostinil 0.032 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602757 | treprostinil 0.032 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602759 | treprostinil 0.048 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602761 | treprostinil 0.048 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602763 | treprostinil 0.064 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602765 | treprostinil 0.064 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602776 | Dryobalanops aromatica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2602779 | pegfilgrastim-pbbk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2602780 | pegfilgrastim-pbbk 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602782 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2602783 | Fylnetra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2602784 | pegfilgrastim-pbbk 10 MG/ML [Fylnetra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2602785 | Fylnetra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2602786 | pegfilgrastim Prefilled Syringe [Fylnetra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2602788 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe [Fylnetra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2602788 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe [Fylnetra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2602839 | magnesium hydroxide 600 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2602839 | magnesium hydroxide 600 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260295 | erythromycin estolate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260299 | diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution [Prohibit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2603 | Clopamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603 | Clopamide | Designated preferred name (PT) | NO | |
RxCUI: 2603 | Clopamide | Full form of descriptor (FN) | NO | |
RxCUI: 2603 | Clopamide | Designated preferred name (PT) | NO | |
RxCUI: 2603 | Clopamide | Full form of descriptor (FN) | NO | |
RxCUI: 26030 | Glycine methyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 26030 | Glycine methyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 260301 | Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution [OmniHIB] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2603037 | propanediol 1-phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2603039 | zinc glycinate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603040 | zinc glycinate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2603041 | zinc glycinate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2603042 | zinc glycinate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2603043 | zinc glycinate 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603043 | zinc glycinate 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260306 | hydrocortisone 10 MG/ML Rectal Cream [Anusol HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260306 | hydrocortisone 10 MG/ML Rectal Cream [Anusol HC-1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603280 | Albatrellus confluens fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2603281 | chromic bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603282 | chromic fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2603287 | Physalis pubescens fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2603288 | polyglyceryl-10 myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260330 | Medrol 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260330 | Medrol 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260330 | Medrol 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260330 | Medrol 4 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 260333 | Altace 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260333 | Altace 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260333 | Altace 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260337 | pentoxifylline 400 MG Extended Release Oral Tablet [Pentopak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260337 | pentoxifylline 400 MG Extended Release Oral Tablet [Pentopak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2603405 | Dermeleve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2603406 | aluminum acetate 2 MG/ML [Dermeleve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603407 | Dermeleve Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603408 | aluminum acetate Topical Cream [Dermeleve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603481 | chromic sulfate decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603483 | colloidal oatmeal 20 MG/ML [Eucerin Eczema Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603484 | Eucerin Eczema Relief Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603485 | colloidal oatmeal Medicated Liquid Soap [Eucerin Eczema Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603488 | racepinephrine hydrochloride 0.0001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2603489 | lidocaine / racepinephrine / tetracaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2603490 | lidocaine / racepinephrine / tetracaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2603491 | lidocaine / racepinephrine / tetracaine Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2603493 | heparan sulfate (porcine 5500 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2603494 | Heparan sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603494 | Heparan sulfate | Designated preferred name (PT) | NO | |
RxCUI: 2603494 | Heparan sulfate | Full form of descriptor (FN) | NO | |
RxCUI: 2603494 | Heparan sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2603499 | measles virus vaccine live, attenuated Schwarz strain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603501 | mumps virus vaccine live, RIT-4385 strain | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2603502 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603503 | mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603504 | rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603505 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2603506 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2603507 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603509 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603510 | Priorix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2603511 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML [Priorix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603512 | Priorix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603513 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603515 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection [Priorix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2603516 | collagen 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603519 | magnesium chloride 71 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603660 | dextromethorphan hydrobromide 29 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603661 | chlorpheniramine maleate 3.5 MG / dextromethorphan HBr 29 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603661 | chlorpheniramine maleate 3.5 MG / dextromethorphan HBr 29 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2603735 | Lagevrio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2603736 | molnupiravir 200 MG [Lagevrio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603737 | Lagevrio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603738 | Lagevrio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603739 | molnupiravir Oral Capsule [Lagevrio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603741 | 1,4-butanedithiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603742 | 1-(ethyltrisulfanyl)propane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603743 | acetaminophen / chlorpheniramine / dextromethorphan Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2603746 | acetaminophen / dextromethorphan Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2603751 | beryllium sulfate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2603752 | beryllium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603757 | Fluorimax Sensitive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2603758 | potassium nitrate 0.05 MG/MG / sodium fluoride 0.011 MG/MG [Fluorimax Sensitive] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603759 | Fluorimax Sensitive Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603760 | Fluorimax Sensitive Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603761 | Fluorimax Sensitive Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603762 | Fluorimax Sensitive Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603763 | potassium nitrate / sodium fluoride Toothpaste [Fluorimax Sensitive] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603766 | Fluorimax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2603767 | sodium fluoride 0.011 MG/MG [Fluorimax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2603768 | Fluorimax Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603769 | Fluorimax Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603770 | Fluorimax Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603771 | Fluorimax Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2603772 | sodium fluoride Toothpaste [Fluorimax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2603774 | Drug-Eluting Contact Lens | Dose Form (DF) | NO | |
RxCUI: 260380 | tropicamide 5 MG/ML Ophthalmic Solution [Tropicacyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260380 | tropicamide 5 MG/ML Ophthalmic Solution [Tropicacyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2603830 | bird-of-paradise tree whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2603830 | bird-of-paradise tree whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2603832 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2603834 | ketotifen 0.019 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2603837 | Acuvue Theravision | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260386 | urofollitropin 300 UNT/ML Injectable Solution [Metrodin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260386 | urofollitropin 300 UNT/ML Injectable Solution [Metrodin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2604 | Clopenthixol | Designated preferred name (PT) | NO | |
RxCUI: 2604 | Clopenthixol | Full form of descriptor (FN) | NO | |
RxCUI: 2604 | Clopenthixol | Designated preferred name (PT) | NO | |
RxCUI: 2604 | Clopenthixol | Full form of descriptor (FN) | NO | |
RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604032 | Lippia graveolens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604033 | withanolide D | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604034 | ferric ferricyanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604035 | sodium starch glycolate type B corn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2604036 | valnemulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604037 | valnemulin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2604040 | diclofenac sodium 0.0125 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604041 | diclofenac / lidocaine Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604044 | ketotifen Drug-Eluting Contact Lens | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604046 | ketotifen 0.019 MG [Acuvue Theravision] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2604047 | Acuvue Theravision Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2604048 | ketotifen Drug-Eluting Contact Lens [Acuvue Theravision] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260408 | prednisolone acetate 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260408 | prednisolone acetate 20 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2604172 | glycerin 1-methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604173 | glycerin 2-methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 26042 | Glycoasparagine | Designated preferred name (PT) | NO | |
RxCUI: 26042 | Glycoasparagine | Full form of descriptor (FN) | NO | |
RxCUI: 260442 | selenium sulfide 25 MG/ML Medicated Shampoo [Exsel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260442 | selenium sulfide 25 MG/ML Medicated Shampoo [Exsel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260443 | selenium sulfide 25 MG/ML Medicated Shampoo [Glo-Sel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260443 | selenium sulfide 25 MG/ML Medicated Shampoo [Glo-Sel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260452 | vitamin B6 25 MG Oral Tablet [Vitelle Nestrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260452 | vitamin B6 25 MG Oral Tablet [Vitelle Nestrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604557 | dimethicone/polyglycerin-3 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604560 | 2-tert-butylcyclohexyl acetate, cis- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604565 | ethylene dodecanedioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604566 | hexyl cinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604569 | PEG-10 beta-sitosteryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604570 | plum juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604571 | POLYQUATERNIUM-80 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604572 | solvent yellow 29 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604575 | Vitis vinifera stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604576 | vonoprazan fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2604577 | vonoprazan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604578 | vutrisiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26046 | Guanidinoacetic acid | Designated preferred name (PT) | NO | |
RxCUI: 26046 | Guanidinoacetic acid | Full form of descriptor (FN) | NO | |
RxCUI: 2604616 | risankizumab-rzaa 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604617 | risankizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604619 | risankizumab-rzaa 60 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604620 | risankizumab-rzaa 60 MG/ML [Skyrizi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2604621 | risankizumab Injection [Skyrizi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604623 | risankizumab-rzaa 60 MG/ML Injection [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604623 | risankizumab-rzaa 60 MG/ML Injection [Skyrizi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604624 | risankizumab Cartridge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604626 | risankizumab-rzaa 150 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604627 | risankizumab Cartridge [Skyrizi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604629 | risankizumab-rzaa 150 MG/ML Cartridge [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604631 | distarch phosphate, corn | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2604632 | N-acetylvaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604633 | beta-phenyl-DL-phenylalanine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2604635 | 1 nighttime (acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 2604635 | 1 nighttime (acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604635 | 1 nighttime (acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604635 | 1 nighttime (acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) / 1 daytime (acetaminophen 1000 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604685 | ilodecakin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2604686 | valacyclovir hydrochloride monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2604686 | valacyclovir hydrochloride monohydrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2604687 | gentian violet 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604689 | ganaxolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 260469 | capsicum 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260469 | capsicum 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260469 | capsicum 0.025 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604690 | ganaxolone 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604691 | ganaxolone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2604692 | ganaxolone Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2604693 | ganaxolone Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604695 | Ztalmy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2604696 | ganaxolone 50 MG/ML [Ztalmy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2604697 | Ztalmy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2604698 | Ztalmy Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2604699 | ganaxolone Oral Suspension [Ztalmy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 260470 | capsaicin 0.2 MG/ML Topical Cream [Capzasin-P] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260470 | capsaicin 0.2 MG/ML Topical Cream [Capzasin-P] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260471 | capsicum 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260471 | capsicum 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260471 | capsicum 0.075 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604767 | Tenotryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2604768 | enrofloxacin 100 MG/ML [Tenotryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2604769 | Tenotryl Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2604770 | enrofloxacin Injectable Solution [Tenotryl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604772 | hypromellose / povidone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2604773 | hypromellose / povidone Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2604774 | hypromellose / povidone Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604776 | pemetrexed tromethamine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2604776 | pemetrexed tromethamine anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2604778 | Lactobacillus acidophilus 17000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604780 | Glycylic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2604781 | salicylic acid 0.17 MG/MG [Glycylic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2604782 | Glycylic Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2604783 | salicylic acid Topical Gel [Glycylic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604785 | vutrisiran 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604786 | vutrisiran Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2604787 | vutrisiran Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604789 | vutrisiran 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2604790 | Amvuttra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2604791 | vutrisiran 50 MG/ML [Amvuttra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2604792 | Amvuttra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2604793 | vutrisiran Prefilled Syringe [Amvuttra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604795 | vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604795 | vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2604796 | vonoprazan 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2604797 | vonoprazan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2604798 | vonoprazan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2604799 | vonoprazan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604877 | lidocaine hydrochloride 0.02 MG/MG [Regenecare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2604878 | lidocaine Topical Gel [Regenecare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2604880 | Chlorhexidine diacetate 200 microgram/mL cutaneous solution | Designated preferred name (PT) | NO | |
RxCUI: 2604880 | Chlorhexidine diacetate 200 microgram/mL cutaneous solution | Full form of descriptor (FN) | NO | |
RxCUI: 2604882 | Chlorhexidine diacetate 500 microgram/mL cutaneous solution | Designated preferred name (PT) | NO | |
RxCUI: 2604882 | Chlorhexidine diacetate 500 microgram/mL cutaneous solution | Full form of descriptor (FN) | NO | |
RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 260494 | chromous chloride 0.001 MG/ML / copper sulfate 0.1 MG/ML / manganese sulfate 0.02 MG/ML / selenious acid 0.015 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [P.T.E.-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260494 | chromous chloride 0.001 MG/ML / copper sulfate 0.1 MG/ML / manganese sulfate 0.02 MG/ML / selenious acid 0.015 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [P.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260499 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-6] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260499 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-6] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26050 | Glycogenin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26050 | Glycogenin | Designated preferred name (PT) | NO | |
RxCUI: 26050 | Glycogenin | Full form of descriptor (FN) | NO | |
RxCUI: 260500 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / molybdenum 0.025 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-7] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260500 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / molybdenum 0.025 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-7] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2605039 | influenza B virus B/Austria/1359417/2021 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605044 | influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605047 | Flulaval Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605048 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605049 | Flulaval Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605050 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605053 | carmustine 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605054 | carmustine 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605054 | carmustine 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605054 | carmustine 300 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605055 | carmustine 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605056 | carmustine 50 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605056 | carmustine 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605056 | carmustine 50 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605083 | influenza A virus A/Darwin/6/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605085 | Limonia acidissima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2605086 | methyl 3-hydroxyhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2605089 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605092 | Fluarix Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605093 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605094 | Fluarix Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605095 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605097 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605098 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605099 | influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 26051 | Glycol monosalicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 26051 | Glycol monosalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 26051 | Glycol monosalicylate | Designated preferred name (PT) | YES | |
RxCUI: 26051 | Glycol monosalicylate | Full form of descriptor (FN) | YES | |
RxCUI: 26051 | Glycol monosalicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605101 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605102 | Fluzone Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605103 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605104 | Fluzone Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605105 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605107 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 26053 | Glycolaldehyde dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 26053 | Glycolaldehyde dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2605536 | Fluad Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605537 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluad Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605538 | Fluad Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605539 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605542 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605548 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605551 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605553 | Afluria Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605554 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605555 | Afluria Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605556 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605560 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605562 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605563 | influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605566 | Flublok Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605567 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605568 | Flublok Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605569 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605574 | vutrisiran sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2605590 | maltobionic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605591 | maltobionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2605592 | sulfur 8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605592 | sulfur 8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605592 | sulfur 8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605718 | 5-hydroxytryptophan Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2605720 | 5-HTP 100 MG Extended Release Oral Tablets | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605720 | 5-HTP 100 MG Extended Release Oral Tablets | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605721 | menthol / panthenol / salicylic acid Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605723 | influenza A virus A/Darwin/11/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605724 | influenza A virus A/Delaware/55/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605725 | influenza B virus B/Singapore/WUH4618/2021 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605726 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605727 | influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605728 | influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605730 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605731 | Flucelvax Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2605732 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605733 | Flucelvax Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2605734 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605736 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605738 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605793 | povidone 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605795 | methylphenidate hydrochloride 63 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605797 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605799 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 26058 | Glycolate oxidase | Designated preferred name (PT) | NO | |
RxCUI: 26058 | Glycolate oxidase | Full form of descriptor (FN) | NO | |
RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605800 | menthol 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2605800 | menthol 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605800 | menthol 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2605801 | anisyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605803 | vivjoa 18-Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2605803 | vivjoa 18-Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605803 | vivjoa 18-Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605942 | methylphenidate hydrochloride 45 MG [Relexxii] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605944 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605944 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet [Relexxii] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605945 | methylphenidate hydrochloride 63 MG [Relexxii] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605947 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2605947 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet [Relexxii] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2605948 | venlafaxine besylate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2605949 | venlafaxine 112.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2605951 | venlafaxine 112.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2606 | Cloprostenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606 | Cloprostenol | Designated preferred name (PT) | NO | |
RxCUI: 2606 | Cloprostenol | Full form of descriptor (FN) | NO | |
RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26060 | Peptide N-glycosidase | Designated preferred name (PT) | NO | |
RxCUI: 26060 | Peptide N-glycosidase | Full form of descriptor (FN) | NO | |
RxCUI: 2606064 | camphor 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2606065 | camphor 0.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606065 | camphor 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606065 | camphor 0.15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2606066 | Coccinia grandis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606067 | surinamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606073 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2606074 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2606075 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606076 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2606077 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2606080 | menthol 9.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2606081 | menthol 9.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606081 | menthol 9.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 26061 | Glycopeptide alpha-N-acetylgalactosaminidase | Designated preferred name (PT) | NO | |
RxCUI: 26061 | Glycopeptide alpha-N-acetylgalactosaminidase | Full form of descriptor (FN) | NO | |
RxCUI: 2606311 | Bursera graveolens fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606312 | zinc pyrithione 10 MG/ML [Dandrene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2606479 | cobalt oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606481 | cobaltous carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606482 | Cryptomeria japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606483 | Canavalia gladiata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606484 | Iomeprol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2606484 | Iomeprol | Designated preferred name (PT) | YES | |
RxCUI: 2606484 | Iomeprol | Full form of descriptor (FN) | YES | |
RxCUI: 2606484 | Iomeprol | Designated preferred name (PT) | YES | |
RxCUI: 2606484 | Iomeprol | Full form of descriptor (FN) | YES | |
RxCUI: 2606489 | pirfenidone 534 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606490 | pirfenidone 534 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606490 | pirfenidone 534 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606493 | keratin, type I cytoskeletal 40 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606512 | trimethylsilyl trihydrogen silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606514 | leuprolide acetate 22.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606515 | leuprolide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 2606543 | Ag - Silver | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
RxCUI: 2606543 | Ag - Silver | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
RxCUI: 2606544 | Julie | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2606545 | levonorgestrel 1.5 MG [Julie] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2606546 | Julie Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2606547 | Julie Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2606548 | levonorgestrel Oral Tablet [Julie] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2606775 | dimethicone propyl PG-betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2606776 | hydrogenated polydecene (3100 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606777 | isostearyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606778 | phosphatidylcholine:ceramide cholinephosphotransferase 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2606779 | zonisamide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606780 | zonisamide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2606781 | zonisamide Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2606783 | Zonisade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2606784 | zonisamide 20 MG/ML [Zonisade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2606785 | Zonisade Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2606786 | Zonisade Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2606787 | zonisamide Oral Suspension [Zonisade] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2606838 | cevimeline hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606840 | cevimeline hydrochloride 30 MG [Evoxac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2606842 | magnesium chloride 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606843 | potassium chloride 0.37 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606844 | sodium acetate 2.22 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606845 | sodium chloride 5.26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2606847 | magnesium chloride 0.3 MG/ML / potassium chloride 0.37 MG/ML / sodium acetate 2.22 MG/ML / sodium chloride 5.26 MG/ML / sodium gluconate 5.02 MG/ML [Physiosol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 260688 | povidone-iodine 100 MG/ML Douche [Betadine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260688 | povidone-iodine 100 MG/ML Douche [Betadine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607 | Dipotassium clorazepate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2607 | Dipotassium clorazepate | Designated preferred name (PT) | YES | |
RxCUI: 2607 | Dipotassium clorazepate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607 | Dipotassium clorazepate | Full form of descriptor (FN) | YES | |
RxCUI: 2607 | Dipotassium clorazepate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607010 | Zantac Reformulated Aug 2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2607011 | famotidine 10 MG [Zantac Reformulated Aug 2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2607012 | Zantac Reformulated Aug 2022 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2607013 | Zantac Reformulated Aug 2022 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2607014 | famotidine Oral Tablet [Zantac Reformulated Aug 2022] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2607015 | Zantac 360 10 MG Oral Tablet, Reformulated Aug 2022 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2607015 | Zantac 360 10 MG Oral Tablet, Reformulated Aug 2022 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607015 | Zantac 360 10 MG Oral Tablet, Reformulated Aug 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607015 | Zantac 360 10 MG Oral Tablet, Reformulated Aug 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607019 | 4'-galactosyllactose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2607025 | menaquinone 6 | Designated preferred name (PT) | NO | |
RxCUI: 2607025 | menaquinone 6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607025 | menaquinone 6 | Full form of descriptor (FN) | NO | |
RxCUI: 2607025 | menaquinone 6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607025 | menaquinone 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2607026 | Fluroxin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2607027 | enrofloxacin 22.7 MG/ML [Fluroxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2607028 | Fluroxin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2607029 | enrofloxacin Injectable Solution [Fluroxin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2607030 | Fluroxin 2.27 % Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2607030 | Fluroxin 2.27 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2607030 | Fluroxin 2.27 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607030 | Fluroxin 2.27 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607147 | isomaltulose anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2607148 | isomaltulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2607150 | Cystoseira tamariscifolia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2607527 | lidocaine 3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2607527 | lidocaine 3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2607527 | lidocaine 3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2607529 | lumateperone 10.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607529 | lumateperone 10.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607529 | lumateperone 10.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2607531 | CAPLYTA 10.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607531 | CAPLYTA 10.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607531 | CAPLYTA 10.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2607533 | lumateperone 21 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607533 | lumateperone 21 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607533 | lumateperone 21 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2607535 | CAPLYTA 21 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607535 | CAPLYTA 21 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607535 | CAPLYTA 21 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2607733 | acalabrutinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2607734 | acalabrutinib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607734 | acalabrutinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607734 | acalabrutinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2607735 | influenza A virus A/Norway/16606/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2607736 | acalabrutinib Oral Tablet [Calquence] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2607737 | CALQUENCE 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2607737 | CALQUENCE 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607737 | CALQUENCE 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607741 | venlafaxine besylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2607742 | influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2607743 | influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2607744 | influenza virus vaccine 2022-2023 Quadrivalent Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2607744 | influenza virus vaccine 2022-2023 Quadrivalent Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607744 | influenza virus vaccine 2022-2023 Quadrivalent Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607745 | FluMist Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2607746 | influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2607747 | FluMist Quadrivalent 2022-2023 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2607748 | FluMist Quadrivalent 2022-2023 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2607749 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2607750 | FluMist Quadrivalent, 2022-2023 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607750 | FluMist Quadrivalent, 2022-2023 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2607750 | FluMist Quadrivalent, 2022-2023 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2607767 | Bifidobacterium bifidum BGN4 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2607768 | alpha-D-galactosidase enzyme 450 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2607769 | alpha-D-galactosidase 450 UNT Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2607769 | alpha-D-galactosidase 450 UNT Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608081 | acetaminophen / dextromethorphan / phenylephrine / triprolidine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2608082 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608082 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608082 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608083 | alpha-D-galactosidase enzyme 450 UNT [Beano] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2608084 | Beano 450 UNT Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2608084 | Beano 450 UNT Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608084 | Beano 450 UNT Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608085 | sodium chloride 7.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2608086 | sodium chloride 0.74 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608086 | sodium chloride 0.74 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608086 | sodium chloride 0.74 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608086 | sodium chloride 0.74 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608093 | 5-aminolevulinic acid only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608093 | 5-aminolevulinic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608094 | Product containing only seratrodast (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2608094 | Product containing only seratrodast (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2608095 | Product containing only seratrodast in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2608095 | Product containing only seratrodast in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2608096 | Hexylresorcinol only product in oromucosal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608096 | Hexylresorcinol only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608097 | Ceftriaxone and sulbactam only product | Designated preferred name (PT) | NO | |
RxCUI: 2608097 | Ceftriaxone and sulbactam only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608098 | Ceftriaxone and sulbactam only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608098 | Ceftriaxone and sulbactam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608099 | Ceftriaxone and tazobactam only product | Designated preferred name (PT) | NO | |
RxCUI: 2608099 | Ceftriaxone and tazobactam only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608100 | Ceftriaxone and tazobactam only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608100 | Ceftriaxone and tazobactam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608101 | Cefuroxime and clavulanic acid only product | Designated preferred name (PT) | NO | |
RxCUI: 2608101 | Cefuroxime and clavulanic acid only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608102 | Cefuroxime and clavulanic acid only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608102 | Cefuroxime and clavulanic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608103 | Dexrazoxane only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608103 | Dexrazoxane only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608104 | Dextran 70 and sodium chloride only product | Designated preferred name (PT) | NO | |
RxCUI: 2608104 | Dextran 70 and sodium chloride only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608105 | Dextran 70 and sodium chloride only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608105 | Dextran 70 and sodium chloride only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608106 | Dicycloverine and mefenamic acid only product | Designated preferred name (PT) | NO | |
RxCUI: 2608106 | Dicycloverine and mefenamic acid only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608106 | Dicycloverine and mefenamic acid only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608107 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2608107 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608107 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2608108 | Ciclesonide and formoterol and tiotropium only product | Designated preferred name (PT) | NO | |
RxCUI: 2608108 | Ciclesonide and formoterol and tiotropium only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608109 | Ciclesonide and formoterol and tiotropium only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608109 | Ciclesonide and formoterol and tiotropium only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608112 | Ciprofloxacin and tinidazole only product | Designated preferred name (PT) | NO | |
RxCUI: 2608112 | Ciprofloxacin and tinidazole only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608113 | Dicycloverine and mefenamic acid only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608113 | Dicycloverine and mefenamic acid only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608113 | Dicycloverine and mefenamic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608114 | Dicycloverine and simeticone only product | Designated preferred name (PT) | NO | |
RxCUI: 2608114 | Dicycloverine and simeticone only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608114 | Dicycloverine and simeticone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608115 | Dicycloverine and simeticone only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608115 | Dicycloverine and simeticone only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608115 | Dicycloverine and simeticone only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608116 | Hydralazine and isosorbide dinitrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608116 | Hydralazine and isosorbide dinitrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608117 | Hydralazine and isosorbide dinitrate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608117 | Hydralazine and isosorbide dinitrate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608118 | Hydrochlorothiazide and levamlodipine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608118 | Hydrochlorothiazide and levamlodipine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608119 | Hydrochlorothiazide and levamlodipine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608119 | Hydrochlorothiazide and levamlodipine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608120 | Hydrochlorothiazide and nebivolol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608120 | Hydrochlorothiazide and nebivolol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608121 | Hydrochlorothiazide and nebivolol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608121 | Hydrochlorothiazide and nebivolol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608122 | Aceclofenac and chlorzoxazone and paracetamol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608122 | Aceclofenac and chlorzoxazone and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608122 | Aceclofenac and chlorzoxazone and paracetamol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608123 | Aceclofenac and chlorzoxazone and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608123 | Aceclofenac and chlorzoxazone and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608123 | Aceclofenac and chlorzoxazone and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608124 | Aspirin and isosorbide mononitrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608124 | Aspirin and isosorbide mononitrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608125 | Atenolol and levamlodipine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608125 | Atenolol and levamlodipine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608126 | Atenolol and levamlodipine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608126 | Atenolol and levamlodipine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608127 | Atorvastatin and clopidogrel only product | Designated preferred name (PT) | NO | |
RxCUI: 2608127 | Atorvastatin and clopidogrel only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608128 | Atorvastatin and clopidogrel only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608128 | Atorvastatin and clopidogrel only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608129 | Atorvastatin and fenofibrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608129 | Atorvastatin and fenofibrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608130 | Atorvastatin and fenofibrate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608130 | Atorvastatin and fenofibrate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608131 | Ciprofloxacin and tinidazole only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608131 | Ciprofloxacin and tinidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608132 | Citicoline only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608132 | Citicoline only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608133 | Clofarabine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608133 | Clofarabine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608134 | Dolutegravir and lamivudine and tenofovir only product | Designated preferred name (PT) | NO | |
RxCUI: 2608134 | Dolutegravir and lamivudine and tenofovir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608135 | Dolutegravir and lamivudine and tenofovir only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608135 | Dolutegravir and lamivudine and tenofovir only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608136 | Drotaverine and mefenamic acid only product | Designated preferred name (PT) | NO | |
RxCUI: 2608136 | Drotaverine and mefenamic acid only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608137 | Drotaverine and mefenamic acid only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608137 | Drotaverine and mefenamic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608138 | Insulin detemir only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608138 | Insulin detemir only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608139 | Iodine and potassium iodide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608139 | Iodine and potassium iodide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608140 | Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product | Designated preferred name (PT) | NO | |
RxCUI: 2608140 | Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608141 | Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608141 | Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608142 | Isosorbide dinitrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608142 | Isosorbide dinitrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608143 | Parecoxib only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608143 | Parecoxib only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608144 | Cetirizine and paracetamol and phenylephrine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608144 | Cetirizine and paracetamol and phenylephrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608144 | Cetirizine and paracetamol and phenylephrine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608145 | Cetirizine and paracetamol and phenylephrine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608145 | Cetirizine and paracetamol and phenylephrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608145 | Cetirizine and paracetamol and phenylephrine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608146 | Chlorzoxazone and diclofenac and paracetamol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608146 | Chlorzoxazone and diclofenac and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608146 | Chlorzoxazone and diclofenac and paracetamol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608147 | Chlorzoxazone and diclofenac and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608147 | Chlorzoxazone and diclofenac and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608147 | Chlorzoxazone and diclofenac and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608148 | Diclofenac and paracetamol and serrapeptase only product | Designated preferred name (PT) | NO | |
RxCUI: 2608148 | Diclofenac and paracetamol and serrapeptase only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608148 | Diclofenac and paracetamol and serrapeptase only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608149 | Diclofenac and paracetamol and serrapeptase only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608149 | Diclofenac and paracetamol and serrapeptase only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608149 | Diclofenac and paracetamol and serrapeptase only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608150 | Mefenamic acid and paracetamol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608150 | Mefenamic acid and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608150 | Mefenamic acid and paracetamol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608151 | Mefenamic acid and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608151 | Mefenamic acid and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608151 | Mefenamic acid and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608152 | Coagulation factor VIII only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608152 | Coagulation factor VIII only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608153 | Duloxetine and mecobalamin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608153 | Duloxetine and mecobalamin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608154 | Duloxetine and mecobalamin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608154 | Duloxetine and mecobalamin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608155 | Isosorbide dinitrate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608155 | Isosorbide dinitrate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608156 | Isosorbide dinitrate only product in oromucosal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608156 | Isosorbide dinitrate only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608157 | Isosorbide dinitrate only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608157 | Isosorbide dinitrate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608158 | Isosorbide dinitrate only product in transdermal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608158 | Isosorbide dinitrate only product in transdermal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608159 | Isosorbide mononitrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608159 | Isosorbide mononitrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608160 | Isosorbide mononitrate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608160 | Isosorbide mononitrate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608161 | Itopride and pantoprazole only product | Designated preferred name (PT) | NO | |
RxCUI: 2608161 | Itopride and pantoprazole only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608162 | Itopride and pantoprazole only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608162 | Itopride and pantoprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608163 | Ivermectin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608163 | Ivermectin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608164 | Benzathine benzylpenicillin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608164 | Benzathine benzylpenicillin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608164 | Benzathine benzylpenicillin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608165 | Benzathine benzylpenicillin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608165 | Benzathine benzylpenicillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608165 | Benzathine benzylpenicillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608166 | Procaine benzylpenicillin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608166 | Procaine benzylpenicillin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608166 | Procaine benzylpenicillin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608167 | Procaine benzylpenicillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608167 | Procaine benzylpenicillin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608167 | Procaine benzylpenicillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608168 | Acetylcysteine and taurine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608168 | Acetylcysteine and taurine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608169 | Acetylcysteine and taurine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608169 | Acetylcysteine and taurine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608170 | Salbutamol and theophylline only product | Designated preferred name (PT) | NO | |
RxCUI: 2608170 | Salbutamol and theophylline only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608170 | Salbutamol and theophylline only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608171 | Estradiol and medroxyprogesterone only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608171 | Estradiol and medroxyprogesterone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608172 | Ethiodised oil only product in oral dose form | British preferred term (PTGB) | NO | |
RxCUI: 2608172 | Ethiodised oil only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608172 | Ethiodised oil only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608173 | Ethiodised oil only product in parenteral dose form | British preferred term (PTGB) | NO | |
RxCUI: 2608173 | Ethiodised oil only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608173 | Ethiodised oil only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608174 | Etofylline and theophylline only product | Designated preferred name (PT) | NO | |
RxCUI: 2608174 | Etofylline and theophylline only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608175 | Levosalbutamol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608175 | Levosalbutamol only product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608175 | Levosalbutamol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608176 | Levamlodipine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608176 | Levamlodipine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608177 | Levamlodipine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608177 | Levamlodipine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608178 | Levocetirizine and montelukast only product | Designated preferred name (PT) | NO | |
RxCUI: 2608178 | Levocetirizine and montelukast only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608179 | Levocetirizine and montelukast only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608179 | Levocetirizine and montelukast only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608180 | Polyvinyl alcohol and povidone only product | Designated preferred name (PT) | NO | |
RxCUI: 2608180 | Polyvinyl alcohol and povidone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608181 | Polyvinyl alcohol and povidone only product in ocular dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608181 | Polyvinyl alcohol and povidone only product in ocular dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608182 | Salbutamol and theophylline only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608182 | Salbutamol and theophylline only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608182 | Salbutamol and theophylline only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608183 | Alemtuzumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608183 | Alemtuzumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608184 | Alglucosidase alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608184 | Alglucosidase alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608185 | Alogliptin and metformin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608185 | Alogliptin and metformin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608186 | Alogliptin and metformin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608186 | Alogliptin and metformin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608187 | Alogliptin and pioglitazone only product | Designated preferred name (PT) | NO | |
RxCUI: 2608187 | Alogliptin and pioglitazone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608188 | Alogliptin and pioglitazone only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608188 | Alogliptin and pioglitazone only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608189 | Bacitracin and neomycin and sulfacetamide only product | Designated preferred name (PT) | NO | |
RxCUI: 2608189 | Bacitracin and neomycin and sulfacetamide only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608190 | Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608190 | Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608191 | Barium sulfate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608191 | Barium sulfate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608192 | Bebtelovimab only product | Designated preferred name (PT) | NO | |
RxCUI: 2608192 | Bebtelovimab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608193 | Bebtelovimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608193 | Bebtelovimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608194 | Beclometasone and levosalbutamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608194 | Beclometasone and levosalbutamol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608194 | Beclometasone and levosalbutamol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608195 | Beclometasone and levosalbutamol only product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608195 | Beclometasone and levosalbutamol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608195 | Beclometasone and levosalbutamol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608196 | Levocloperastine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608196 | Levocloperastine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608197 | Levocloperastine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608197 | Levocloperastine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608198 | Levomefolic acid and mecobalamin and pyridoxal only product | Designated preferred name (PT) | NO | |
RxCUI: 2608198 | Levomefolic acid and mecobalamin and pyridoxal only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608199 | Levomefolic acid and mecobalamin and pyridoxal only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608199 | Levomefolic acid and mecobalamin and pyridoxal only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608200 | Levosulpiride and rabeprazole only product | Designated preferred name (PT) | NO | |
RxCUI: 2608200 | Levosulpiride and rabeprazole only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608201 | Levosulpiride and rabeprazole only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608201 | Levosulpiride and rabeprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608202 | Alprazolam and propranolol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608202 | Alprazolam and propranolol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608203 | Alprazolam and propranolol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608203 | Alprazolam and propranolol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608204 | Alprostadil only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608204 | Alprostadil only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608205 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608205 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608205 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608206 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608206 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608206 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608207 | Ambroxol and guaifenesin and terbutaline only product | Designated preferred name (PT) | NO | |
RxCUI: 2608207 | Ambroxol and guaifenesin and terbutaline only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608208 | Ambroxol and guaifenesin and terbutaline only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608208 | Ambroxol and guaifenesin and terbutaline only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608209 | Amikacin only product in ocular dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608209 | Amikacin only product in ocular dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608210 | Etofylline and theophylline only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608210 | Etofylline and theophylline only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608211 | Etofylline and theophylline only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608211 | Etofylline and theophylline only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608212 | Etoricoxib and thiocolchicoside only product | Designated preferred name (PT) | NO | |
RxCUI: 2608212 | Etoricoxib and thiocolchicoside only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608213 | Etoricoxib and thiocolchicoside only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608213 | Etoricoxib and thiocolchicoside only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608214 | Mecobalamin and piracetam only product | Designated preferred name (PT) | NO | |
RxCUI: 2608214 | Mecobalamin and piracetam only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608215 | Mecobalamin and piracetam only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608215 | Mecobalamin and piracetam only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608217 | Meglumine antimoniate only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608217 | Meglumine antimoniate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608218 | Metformin and voglibose only product | Designated preferred name (PT) | NO | |
RxCUI: 2608218 | Metformin and voglibose only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608219 | Amisulpride only product in oromucosal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608219 | Amisulpride only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608220 | Amlodipine and atenolol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608220 | Amlodipine and atenolol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608221 | Amlodipine and atenolol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608221 | Amlodipine and atenolol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608222 | Amlodipine and metoprolol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608222 | Amlodipine and metoprolol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608223 | Amlodipine and metoprolol only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608223 | Amlodipine and metoprolol only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608224 | Ammonia only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608224 | Ammonia only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608225 | Benzoxonium and lidocaine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608225 | Benzoxonium and lidocaine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608226 | Benzoxonium and lidocaine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608226 | Benzoxonium and lidocaine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608227 | Fluticasone and formoterol only product | Designated preferred name (PT) | NO | |
RxCUI: 2608227 | Fluticasone and formoterol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608228 | Fluticasone and formoterol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608228 | Fluticasone and formoterol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608229 | Gabapentin and mecobalamin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608229 | Gabapentin and mecobalamin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608230 | Gabapentin and mecobalamin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608230 | Gabapentin and mecobalamin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608231 | Gabapentin and nortriptyline only product | Designated preferred name (PT) | NO | |
RxCUI: 2608231 | Gabapentin and nortriptyline only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608232 | Gabapentin and nortriptyline only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608232 | Gabapentin and nortriptyline only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608233 | Metformin and voglibose only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608233 | Metformin and voglibose only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608234 | Methoxy polyethylene glycol-epoetin beta only product | Designated preferred name (PT) | NO | |
RxCUI: 2608234 | Methoxy polyethylene glycol-epoetin beta only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608235 | Methoxy polyethylene glycol-epoetin beta only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608235 | Methoxy polyethylene glycol-epoetin beta only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608236 | Metoprolol and telmisartan only product | Designated preferred name (PT) | NO | |
RxCUI: 2608236 | Metoprolol and telmisartan only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608237 | Metoprolol and telmisartan only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608237 | Metoprolol and telmisartan only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608238 | Calamine and zinc oxide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608238 | Calamine and zinc oxide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608239 | Calcium chloride and potassium chloride and sodium chloride and sodium lactate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608239 | Calcium chloride and potassium chloride and sodium chloride and sodium lactate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608240 | Calcium chloride and potassium chloride and sodium chloride and sodium lactate only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608240 | Calcium chloride and potassium chloride and sodium chloride and sodium lactate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608241 | Carbazochrome only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608241 | Carbazochrome only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608242 | Gliclazide and metformin only product | Designated preferred name (PT) | NO | |
RxCUI: 2608242 | Gliclazide and metformin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608243 | Gliclazide and metformin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608243 | Gliclazide and metformin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608244 | Glucose and lidocaine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608244 | Glucose and lidocaine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608245 | Glucose and lidocaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608245 | Glucose and lidocaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608246 | Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product | Designated preferred name (PT) | NO | |
RxCUI: 2608246 | Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608247 | Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608247 | Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608248 | Glucose and potassium chloride and sodium chloride and sodium citrate only product | Designated preferred name (PT) | NO | |
RxCUI: 2608248 | Glucose and potassium chloride and sodium chloride and sodium citrate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608249 | Glucose and potassium chloride and sodium chloride and sodium citrate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608249 | Glucose and potassium chloride and sodium chloride and sodium citrate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608250 | Artenimol and piperaquine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608250 | Artenimol and piperaquine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608251 | Artenimol and piperaquine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608251 | Artenimol and piperaquine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608252 | Artesunate and pyronaridine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608252 | Artesunate and pyronaridine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608253 | Artesunate and pyronaridine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608253 | Artesunate and pyronaridine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608254 | Caspofungin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608254 | Caspofungin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608255 | Castor oil and colophony only product | Designated preferred name (PT) | NO | |
RxCUI: 2608255 | Castor oil and colophony only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608256 | Cefatrizine only product | Designated preferred name (PT) | NO | |
RxCUI: 2608256 | Cefatrizine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608257 | Cefatrizine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608257 | Cefatrizine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608258 | Cefoperazone and sulbactam only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608258 | Cefoperazone and sulbactam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608259 | Mitoxantrone only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608259 | Mitoxantrone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608260 | Molnupiravir only product | Designated preferred name (PT) | NO | |
RxCUI: 2608260 | Molnupiravir only product | Full form of descriptor (FN) | NO | |
RxCUI: 2608261 | Molnupiravir only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2608261 | Molnupiravir only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2608262 | Product containing only silver (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2608262 | Product containing only silver (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2608263 | Product containing only silver in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2608263 | Product containing only silver in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2608264 | Product containing only sodium thiosulfate (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2608264 | Product containing only sodium thiosulfate (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2608265 | Product containing only sodium thiosulfate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2608265 | Product containing only sodium thiosulfate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2608266 | Product containing only thyrotropin alfa in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2608266 | Product containing only thyrotropin alfa in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2608267 | Cw*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608267 | Cw*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608268 | Cw*0102 | Designated preferred name (PT) | NO | |
RxCUI: 2608268 | Cw*0102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608269 | Cw*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608269 | Cw*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608270 | Cw*02021 | Designated preferred name (PT) | NO | |
RxCUI: 2608270 | Cw*02021 | Full form of descriptor (FN) | NO | |
RxCUI: 2608271 | Cw*02022 | Designated preferred name (PT) | NO | |
RxCUI: 2608271 | Cw*02022 | Full form of descriptor (FN) | NO | |
RxCUI: 2608272 | Cw*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608272 | Cw*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608273 | Cw*0302 | Designated preferred name (PT) | NO | |
RxCUI: 2608273 | Cw*0302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608274 | Cw*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608274 | Cw*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608275 | Cw*0501 | Designated preferred name (PT) | NO | |
RxCUI: 2608275 | Cw*0501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608276 | Cw*0601 | Designated preferred name (PT) | NO | |
RxCUI: 2608276 | Cw*0601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608277 | Cw*0701 | Designated preferred name (PT) | NO | |
RxCUI: 2608277 | Cw*0701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608278 | Cw*0702 | Designated preferred name (PT) | NO | |
RxCUI: 2608278 | Cw*0702 | Full form of descriptor (FN) | NO | |
RxCUI: 2608279 | Cw*0801 | Designated preferred name (PT) | NO | |
RxCUI: 2608279 | Cw*0801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608280 | Cw*0802 | Designated preferred name (PT) | NO | |
RxCUI: 2608280 | Cw*0802 | Full form of descriptor (FN) | NO | |
RxCUI: 2608281 | Cw*1201 | Designated preferred name (PT) | NO | |
RxCUI: 2608281 | Cw*1201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608282 | Cw*1202 | Designated preferred name (PT) | NO | |
RxCUI: 2608282 | Cw*1202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608283 | Cw*1301 | Designated preferred name (PT) | NO | |
RxCUI: 2608283 | Cw*1301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608284 | Cw*1401 | Designated preferred name (PT) | NO | |
RxCUI: 2608284 | Cw*1401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608285 | DPA1*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608285 | DPA1*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608286 | DPA1*0102 | Designated preferred name (PT) | NO | |
RxCUI: 2608286 | DPA1*0102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608287 | DPA1*0103 | Designated preferred name (PT) | NO | |
RxCUI: 2608287 | DPA1*0103 | Full form of descriptor (FN) | NO | |
RxCUI: 2608288 | DPA1*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608288 | DPA1*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608289 | DPA1*02021 | Designated preferred name (PT) | NO | |
RxCUI: 2608289 | DPA1*02021 | Full form of descriptor (FN) | NO | |
RxCUI: 2608290 | DPA1*02022 | Designated preferred name (PT) | NO | |
RxCUI: 2608290 | DPA1*02022 | Full form of descriptor (FN) | NO | |
RxCUI: 2608291 | DPA1*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608291 | DPA1*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608292 | DPA1*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608292 | DPA1*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608293 | DPB1*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608293 | DPB1*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608294 | DPB1*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608294 | DPB1*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608295 | DPB1*02011 | Designated preferred name (PT) | NO | |
RxCUI: 2608295 | DPB1*02011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608296 | DPB1*02012 | Designated preferred name (PT) | NO | |
RxCUI: 2608296 | DPB1*02012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608297 | DPB1*0202 | Designated preferred name (PT) | NO | |
RxCUI: 2608297 | DPB1*0202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608298 | DPB1*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608298 | DPB1*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608299 | DPB1*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608299 | DPB1*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 26083 | Promastigote surface endopeptidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 26083 | Promastigote surface endopeptidase | Designated preferred name (PT) | NO | |
RxCUI: 26083 | Promastigote surface endopeptidase | Full form of descriptor (FN) | NO | |
RxCUI: 26083 | Promastigote surface endopeptidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608300 | DPB1*0402 | Designated preferred name (PT) | NO | |
RxCUI: 2608300 | DPB1*0402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608301 | DPB1*0501 | Designated preferred name (PT) | NO | |
RxCUI: 2608301 | DPB1*0501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608302 | DPB1*0601 | Designated preferred name (PT) | NO | |
RxCUI: 2608302 | DPB1*0601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608303 | DPB1*0801 | Designated preferred name (PT) | NO | |
RxCUI: 2608303 | DPB1*0801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608304 | DPB1*0901 | Designated preferred name (PT) | NO | |
RxCUI: 2608304 | DPB1*0901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608305 | DPB1*1101 | Designated preferred name (PT) | NO | |
RxCUI: 2608305 | DPB1*1101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608306 | DPB1*1301 | Designated preferred name (PT) | NO | |
RxCUI: 2608306 | DPB1*1301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608307 | DPB1*1401 | Designated preferred name (PT) | NO | |
RxCUI: 2608307 | DPB1*1401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608308 | DPB1*1501 | Designated preferred name (PT) | NO | |
RxCUI: 2608308 | DPB1*1501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608309 | DPB1*1601 | Designated preferred name (PT) | NO | |
RxCUI: 2608309 | DPB1*1601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608310 | DPB1*1701 | Designated preferred name (PT) | NO | |
RxCUI: 2608310 | DPB1*1701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608311 | DPB1*1801 | Designated preferred name (PT) | NO | |
RxCUI: 2608311 | DPB1*1801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608312 | DPB1*1901 | Designated preferred name (PT) | NO | |
RxCUI: 2608312 | DPB1*1901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608313 | DPB1*2001 | Designated preferred name (PT) | NO | |
RxCUI: 2608313 | DPB1*2001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608314 | DPB1*2101 | Designated preferred name (PT) | NO | |
RxCUI: 2608314 | DPB1*2101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608315 | DPB1*2201 | Designated preferred name (PT) | NO | |
RxCUI: 2608315 | DPB1*2201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608316 | DPB1*2301 | Designated preferred name (PT) | NO | |
RxCUI: 2608316 | DPB1*2301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608317 | DPB1*2401 | Designated preferred name (PT) | NO | |
RxCUI: 2608317 | DPB1*2401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608318 | DPB1*2501 | Designated preferred name (PT) | NO | |
RxCUI: 2608318 | DPB1*2501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608319 | DPB1*2601 | Designated preferred name (PT) | NO | |
RxCUI: 2608319 | DPB1*2601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608320 | DPB1*2701 | Designated preferred name (PT) | NO | |
RxCUI: 2608320 | DPB1*2701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608321 | DPB1*2801 | Designated preferred name (PT) | NO | |
RxCUI: 2608321 | DPB1*2801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608322 | DPB1*2901 | Designated preferred name (PT) | NO | |
RxCUI: 2608322 | DPB1*2901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608323 | DPB1*3001 | Designated preferred name (PT) | NO | |
RxCUI: 2608323 | DPB1*3001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608324 | DPB1*3101 | Designated preferred name (PT) | NO | |
RxCUI: 2608324 | DPB1*3101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608325 | DPB1*3201 | Designated preferred name (PT) | NO | |
RxCUI: 2608325 | DPB1*3201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608326 | DPB1*3301 | Designated preferred name (PT) | NO | |
RxCUI: 2608326 | DPB1*3301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608327 | DPB1*3401 | Designated preferred name (PT) | NO | |
RxCUI: 2608327 | DPB1*3401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608328 | DPB1*3501 | Designated preferred name (PT) | NO | |
RxCUI: 2608328 | DPB1*3501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608329 | DPB1*3601 | Designated preferred name (PT) | NO | |
RxCUI: 2608329 | DPB1*3601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608330 | DPB199*2901 | Designated preferred name (PT) | NO | |
RxCUI: 2608330 | DPB199*2901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608331 | DQA1*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608331 | DQA1*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608332 | DQA1*0102 | Designated preferred name (PT) | NO | |
RxCUI: 2608332 | DQA1*0102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608333 | DQA1*0103 | Designated preferred name (PT) | NO | |
RxCUI: 2608333 | DQA1*0103 | Full form of descriptor (FN) | NO | |
RxCUI: 2608334 | DQA1*0104 | Designated preferred name (PT) | NO | |
RxCUI: 2608334 | DQA1*0104 | Full form of descriptor (FN) | NO | |
RxCUI: 2608335 | DQA1*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608335 | DQA1*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608336 | DQA1*03011 | Designated preferred name (PT) | NO | |
RxCUI: 2608336 | DQA1*03011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608337 | DQA1*03012 | Designated preferred name (PT) | NO | |
RxCUI: 2608337 | DQA1*03012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608338 | DQA1*0302 | Designated preferred name (PT) | NO | |
RxCUI: 2608338 | DQA1*0302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608339 | DQA1*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608339 | DQA1*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608340 | DQA1*0501 | Designated preferred name (PT) | NO | |
RxCUI: 2608340 | DQA1*0501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608341 | DQA1*05011 | Designated preferred name (PT) | NO | |
RxCUI: 2608341 | DQA1*05011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608342 | DQA1*05012 | Designated preferred name (PT) | NO | |
RxCUI: 2608342 | DQA1*05012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608343 | DQA1*05013 | Designated preferred name (PT) | NO | |
RxCUI: 2608343 | DQA1*05013 | Full form of descriptor (FN) | NO | |
RxCUI: 2608344 | DQA1*0601 | Designated preferred name (PT) | NO | |
RxCUI: 2608344 | DQA1*0601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608345 | DQB1*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608345 | DQB1*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608346 | DQB1*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608346 | DQB1*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608347 | DQB1*0302 | Designated preferred name (PT) | NO | |
RxCUI: 2608347 | DQB1*0302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608348 | DQB1*03031 | Designated preferred name (PT) | NO | |
RxCUI: 2608348 | DQB1*03031 | Full form of descriptor (FN) | NO | |
RxCUI: 2608349 | DQB1*03032 | Designated preferred name (PT) | NO | |
RxCUI: 2608349 | DQB1*03032 | Full form of descriptor (FN) | NO | |
RxCUI: 2608350 | DQB1*0304 | Designated preferred name (PT) | NO | |
RxCUI: 2608350 | DQB1*0304 | Full form of descriptor (FN) | NO | |
RxCUI: 2608351 | DQB1*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608351 | DQB1*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608352 | DQB1*0402 | Designated preferred name (PT) | NO | |
RxCUI: 2608352 | DQB1*0402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608353 | DQB1*0501 | Designated preferred name (PT) | NO | |
RxCUI: 2608353 | DQB1*0501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608354 | DQB1*0502 | Designated preferred name (PT) | NO | |
RxCUI: 2608354 | DQB1*0502 | Full form of descriptor (FN) | NO | |
RxCUI: 2608355 | DQB1*05031 | Designated preferred name (PT) | NO | |
RxCUI: 2608355 | DQB1*05031 | Full form of descriptor (FN) | NO | |
RxCUI: 2608356 | DQB1*05032 | Designated preferred name (PT) | NO | |
RxCUI: 2608356 | DQB1*05032 | Full form of descriptor (FN) | NO | |
RxCUI: 2608357 | DQB1*0504 | Designated preferred name (PT) | NO | |
RxCUI: 2608357 | DQB1*0504 | Full form of descriptor (FN) | NO | |
RxCUI: 2608358 | DQB1*0601 | Designated preferred name (PT) | NO | |
RxCUI: 2608358 | DQB1*0601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608359 | DQB1*0602 | Designated preferred name (PT) | NO | |
RxCUI: 2608359 | DQB1*0602 | Full form of descriptor (FN) | NO | |
RxCUI: 2608360 | DQB1*0603 | Designated preferred name (PT) | NO | |
RxCUI: 2608360 | DQB1*0603 | Full form of descriptor (FN) | NO | |
RxCUI: 2608361 | DQB1*0604 | Designated preferred name (PT) | NO | |
RxCUI: 2608361 | DQB1*0604 | Full form of descriptor (FN) | NO | |
RxCUI: 2608362 | DQB1*0605 | Designated preferred name (PT) | NO | |
RxCUI: 2608362 | DQB1*0605 | Full form of descriptor (FN) | NO | |
RxCUI: 2608363 | DQB1*0606 | Designated preferred name (PT) | NO | |
RxCUI: 2608363 | DQB1*0606 | Full form of descriptor (FN) | NO | |
RxCUI: 2608364 | DRB1*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608364 | DRB1*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608365 | DRB1*0102 | Designated preferred name (PT) | NO | |
RxCUI: 2608365 | DRB1*0102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608366 | DRB1*0103 | Designated preferred name (PT) | NO | |
RxCUI: 2608366 | DRB1*0103 | Full form of descriptor (FN) | NO | |
RxCUI: 2608367 | DRB1*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608367 | DRB1*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608368 | DRB1*0302 | Designated preferred name (PT) | NO | |
RxCUI: 2608368 | DRB1*0302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608369 | DRB1*0303 | Designated preferred name (PT) | NO | |
RxCUI: 2608369 | DRB1*0303 | Full form of descriptor (FN) | NO | |
RxCUI: 2608370 | DRB1*0401 | Designated preferred name (PT) | NO | |
RxCUI: 2608370 | DRB1*0401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608371 | DRB1*0402 | Designated preferred name (PT) | NO | |
RxCUI: 2608371 | DRB1*0402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608372 | DRB1*0403 | Designated preferred name (PT) | NO | |
RxCUI: 2608372 | DRB1*0403 | Full form of descriptor (FN) | NO | |
RxCUI: 2608373 | DRB1*0404 | Designated preferred name (PT) | NO | |
RxCUI: 2608373 | DRB1*0404 | Full form of descriptor (FN) | NO | |
RxCUI: 2608374 | DRB1*0405 | Designated preferred name (PT) | NO | |
RxCUI: 2608374 | DRB1*0405 | Full form of descriptor (FN) | NO | |
RxCUI: 2608375 | DRB1*0406 | Designated preferred name (PT) | NO | |
RxCUI: 2608375 | DRB1*0406 | Full form of descriptor (FN) | NO | |
RxCUI: 2608376 | DRB1*0407 | Designated preferred name (PT) | NO | |
RxCUI: 2608376 | DRB1*0407 | Full form of descriptor (FN) | NO | |
RxCUI: 2608377 | DRB1*0408 | Designated preferred name (PT) | NO | |
RxCUI: 2608377 | DRB1*0408 | Full form of descriptor (FN) | NO | |
RxCUI: 2608378 | DRB1*0409 | Designated preferred name (PT) | NO | |
RxCUI: 2608378 | DRB1*0409 | Full form of descriptor (FN) | NO | |
RxCUI: 2608379 | DRB1*0410 | Designated preferred name (PT) | NO | |
RxCUI: 2608379 | DRB1*0410 | Full form of descriptor (FN) | NO | |
RxCUI: 2608380 | DRB1*0411 | Designated preferred name (PT) | NO | |
RxCUI: 2608380 | DRB1*0411 | Full form of descriptor (FN) | NO | |
RxCUI: 2608381 | DRB1*0412 | Designated preferred name (PT) | NO | |
RxCUI: 2608381 | DRB1*0412 | Full form of descriptor (FN) | NO | |
RxCUI: 2608382 | DRB1*0701 | Designated preferred name (PT) | NO | |
RxCUI: 2608382 | DRB1*0701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608383 | DRB1*0702 | Designated preferred name (PT) | NO | |
RxCUI: 2608383 | DRB1*0702 | Full form of descriptor (FN) | NO | |
RxCUI: 2608384 | DRB1*0801 | Designated preferred name (PT) | NO | |
RxCUI: 2608384 | DRB1*0801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608385 | DRB1*08021 | Designated preferred name (PT) | NO | |
RxCUI: 2608385 | DRB1*08021 | Full form of descriptor (FN) | NO | |
RxCUI: 2608386 | DRB1*08022 | Designated preferred name (PT) | NO | |
RxCUI: 2608386 | DRB1*08022 | Full form of descriptor (FN) | NO | |
RxCUI: 2608387 | DRB1*08031 | Designated preferred name (PT) | NO | |
RxCUI: 2608387 | DRB1*08031 | Full form of descriptor (FN) | NO | |
RxCUI: 2608388 | DRB1*08032 | Designated preferred name (PT) | NO | |
RxCUI: 2608388 | DRB1*08032 | Full form of descriptor (FN) | NO | |
RxCUI: 2608389 | DRB1*0804 | Designated preferred name (PT) | NO | |
RxCUI: 2608389 | DRB1*0804 | Full form of descriptor (FN) | NO | |
RxCUI: 2608390 | DRB1*0805 | Designated preferred name (PT) | NO | |
RxCUI: 2608390 | DRB1*0805 | Full form of descriptor (FN) | NO | |
RxCUI: 2608391 | DRB1*09011 | Designated preferred name (PT) | NO | |
RxCUI: 2608391 | DRB1*09011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608392 | DRB1*09012 | Designated preferred name (PT) | NO | |
RxCUI: 2608392 | DRB1*09012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608393 | DRB1*1001 | Designated preferred name (PT) | NO | |
RxCUI: 2608393 | DRB1*1001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608394 | DRB1*11011 | Designated preferred name (PT) | NO | |
RxCUI: 2608394 | DRB1*11011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608395 | DRB1*11012 | Designated preferred name (PT) | NO | |
RxCUI: 2608395 | DRB1*11012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608396 | DRB1*1102 | Designated preferred name (PT) | NO | |
RxCUI: 2608396 | DRB1*1102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608397 | DRB1*1103 | Designated preferred name (PT) | NO | |
RxCUI: 2608397 | DRB1*1103 | Full form of descriptor (FN) | NO | |
RxCUI: 2608398 | DRB1*11041 | Designated preferred name (PT) | NO | |
RxCUI: 2608398 | DRB1*11041 | Full form of descriptor (FN) | NO | |
RxCUI: 2608399 | DRB1*11042 | Designated preferred name (PT) | NO | |
RxCUI: 2608399 | DRB1*11042 | Full form of descriptor (FN) | NO | |
RxCUI: 2608400 | DRB1*1105 | Designated preferred name (PT) | NO | |
RxCUI: 2608400 | DRB1*1105 | Full form of descriptor (FN) | NO | |
RxCUI: 2608401 | DRB1*1202 | Designated preferred name (PT) | NO | |
RxCUI: 2608401 | DRB1*1202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608402 | DRB1*1301 | Designated preferred name (PT) | NO | |
RxCUI: 2608402 | DRB1*1301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608403 | DRB1*1302 | Designated preferred name (PT) | NO | |
RxCUI: 2608403 | DRB1*1302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608404 | DRB1*1303 | Designated preferred name (PT) | NO | |
RxCUI: 2608404 | DRB1*1303 | Full form of descriptor (FN) | NO | |
RxCUI: 2608405 | DRB1*1304 | Designated preferred name (PT) | NO | |
RxCUI: 2608405 | DRB1*1304 | Full form of descriptor (FN) | NO | |
RxCUI: 2608406 | DRB1*1305 | Designated preferred name (PT) | NO | |
RxCUI: 2608406 | DRB1*1305 | Full form of descriptor (FN) | NO | |
RxCUI: 2608407 | DRB1*1306 | Designated preferred name (PT) | NO | |
RxCUI: 2608407 | DRB1*1306 | Full form of descriptor (FN) | NO | |
RxCUI: 2608408 | DRB1*1401 | Designated preferred name (PT) | NO | |
RxCUI: 2608408 | DRB1*1401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608409 | DRB1*1402 | Designated preferred name (PT) | NO | |
RxCUI: 2608409 | DRB1*1402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608410 | DRB1*1403 | Designated preferred name (PT) | NO | |
RxCUI: 2608410 | DRB1*1403 | Full form of descriptor (FN) | NO | |
RxCUI: 2608411 | DRB1*1404 | Designated preferred name (PT) | NO | |
RxCUI: 2608411 | DRB1*1404 | Full form of descriptor (FN) | NO | |
RxCUI: 2608412 | DRB1*1405 | Designated preferred name (PT) | NO | |
RxCUI: 2608412 | DRB1*1405 | Full form of descriptor (FN) | NO | |
RxCUI: 2608413 | DRB1*1406 | Designated preferred name (PT) | NO | |
RxCUI: 2608413 | DRB1*1406 | Full form of descriptor (FN) | NO | |
RxCUI: 2608414 | DRB1*1407 | Designated preferred name (PT) | NO | |
RxCUI: 2608414 | DRB1*1407 | Full form of descriptor (FN) | NO | |
RxCUI: 2608415 | DRB1*1408 | Designated preferred name (PT) | NO | |
RxCUI: 2608415 | DRB1*1408 | Full form of descriptor (FN) | NO | |
RxCUI: 2608416 | DRB1*1409 | Designated preferred name (PT) | NO | |
RxCUI: 2608416 | DRB1*1409 | Full form of descriptor (FN) | NO | |
RxCUI: 2608417 | DRB1*1410 | Designated preferred name (PT) | NO | |
RxCUI: 2608417 | DRB1*1410 | Full form of descriptor (FN) | NO | |
RxCUI: 2608418 | DRB1*1501 | Designated preferred name (PT) | NO | |
RxCUI: 2608418 | DRB1*1501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608419 | DRB1*1502 | Designated preferred name (PT) | NO | |
RxCUI: 2608419 | DRB1*1502 | Full form of descriptor (FN) | NO | |
RxCUI: 2608420 | DRB1*1503 | Designated preferred name (PT) | NO | |
RxCUI: 2608420 | DRB1*1503 | Full form of descriptor (FN) | NO | |
RxCUI: 2608421 | DRB1*1601 | Designated preferred name (PT) | NO | |
RxCUI: 2608421 | DRB1*1601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608422 | DRB1*1602 | Designated preferred name (PT) | NO | |
RxCUI: 2608422 | DRB1*1602 | Full form of descriptor (FN) | NO | |
RxCUI: 2608423 | DRB3*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608423 | DRB3*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608424 | DRB3*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608424 | DRB3*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608425 | DRB3*0202 | Designated preferred name (PT) | NO | |
RxCUI: 2608425 | DRB3*0202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608426 | DRB3*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608426 | DRB3*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608427 | DRB4*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608427 | DRB4*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608428 | DRB5*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608428 | DRB5*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608429 | DRB5*0102 | Designated preferred name (PT) | NO | |
RxCUI: 2608429 | DRB5*0102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608430 | DRB5*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608430 | DRB5*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608431 | DRB5*0202 | Designated preferred name (PT) | NO | |
RxCUI: 2608431 | DRB5*0202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608432 | B*0701 | Designated preferred name (PT) | NO | |
RxCUI: 2608432 | B*0701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608433 | B*0702 | Designated preferred name (PT) | NO | |
RxCUI: 2608433 | B*0702 | Full form of descriptor (FN) | NO | |
RxCUI: 2608434 | B*0703 | Designated preferred name (PT) | NO | |
RxCUI: 2608434 | B*0703 | Full form of descriptor (FN) | NO | |
RxCUI: 2608435 | B*0801 | Designated preferred name (PT) | NO | |
RxCUI: 2608435 | B*0801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608436 | B*1301 | Designated preferred name (PT) | NO | |
RxCUI: 2608436 | B*1301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608437 | B*1302 | Designated preferred name (PT) | NO | |
RxCUI: 2608437 | B*1302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608438 | B*1401 | Designated preferred name (PT) | NO | |
RxCUI: 2608438 | B*1401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608439 | B*1402 | Designated preferred name (PT) | NO | |
RxCUI: 2608439 | B*1402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608440 | B*1501 | Designated preferred name (PT) | NO | |
RxCUI: 2608440 | B*1501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608441 | B*1502 | Designated preferred name (PT) | NO | |
RxCUI: 2608441 | B*1502 | Full form of descriptor (FN) | NO | |
RxCUI: 2608442 | B*1503 | Designated preferred name (PT) | NO | |
RxCUI: 2608442 | B*1503 | Full form of descriptor (FN) | NO | |
RxCUI: 2608443 | B*1504 | Designated preferred name (PT) | NO | |
RxCUI: 2608443 | B*1504 | Full form of descriptor (FN) | NO | |
RxCUI: 2608444 | B*1801 | Designated preferred name (PT) | NO | |
RxCUI: 2608444 | B*1801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608445 | B*2701 | Designated preferred name (PT) | NO | |
RxCUI: 2608445 | B*2701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608446 | B*2702 | Designated preferred name (PT) | NO | |
RxCUI: 2608446 | B*2702 | Full form of descriptor (FN) | NO | |
RxCUI: 2608447 | B*2703 | Designated preferred name (PT) | NO | |
RxCUI: 2608447 | B*2703 | Full form of descriptor (FN) | NO | |
RxCUI: 2608448 | B*2704 | Designated preferred name (PT) | NO | |
RxCUI: 2608448 | B*2704 | Full form of descriptor (FN) | NO | |
RxCUI: 2608449 | B*2705 | Designated preferred name (PT) | NO | |
RxCUI: 2608449 | B*2705 | Full form of descriptor (FN) | NO | |
RxCUI: 2608450 | B*2706 | Designated preferred name (PT) | NO | |
RxCUI: 2608450 | B*2706 | Full form of descriptor (FN) | NO | |
RxCUI: 2608451 | B*2707 | Designated preferred name (PT) | NO | |
RxCUI: 2608451 | B*2707 | Full form of descriptor (FN) | NO | |
RxCUI: 2608452 | B*3501 | Designated preferred name (PT) | NO | |
RxCUI: 2608452 | B*3501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608453 | B*3502 | Designated preferred name (PT) | NO | |
RxCUI: 2608453 | B*3502 | Full form of descriptor (FN) | NO | |
RxCUI: 2608454 | B*3503 | Designated preferred name (PT) | NO | |
RxCUI: 2608454 | B*3503 | Full form of descriptor (FN) | NO | |
RxCUI: 2608455 | B*3504 | Designated preferred name (PT) | NO | |
RxCUI: 2608455 | B*3504 | Full form of descriptor (FN) | NO | |
RxCUI: 2608456 | B*3505 | Designated preferred name (PT) | NO | |
RxCUI: 2608456 | B*3505 | Full form of descriptor (FN) | NO | |
RxCUI: 2608457 | B*3506 | Designated preferred name (PT) | NO | |
RxCUI: 2608457 | B*3506 | Full form of descriptor (FN) | NO | |
RxCUI: 2608458 | B*3701 | Designated preferred name (PT) | NO | |
RxCUI: 2608458 | B*3701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608459 | B*3801 | Designated preferred name (PT) | NO | |
RxCUI: 2608459 | B*3801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608460 | B*3901 | Designated preferred name (PT) | NO | |
RxCUI: 2608460 | B*3901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608461 | B*3902 | Designated preferred name (PT) | NO | |
RxCUI: 2608461 | B*3902 | Full form of descriptor (FN) | NO | |
RxCUI: 2608462 | B*4001 | Designated preferred name (PT) | NO | |
RxCUI: 2608462 | B*4001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608463 | B*4002 | Designated preferred name (PT) | NO | |
RxCUI: 2608463 | B*4002 | Full form of descriptor (FN) | NO | |
RxCUI: 2608464 | B*4003 | Designated preferred name (PT) | NO | |
RxCUI: 2608464 | B*4003 | Full form of descriptor (FN) | NO | |
RxCUI: 2608465 | B*4004 | Designated preferred name (PT) | NO | |
RxCUI: 2608465 | B*4004 | Full form of descriptor (FN) | NO | |
RxCUI: 2608466 | B*4005 | Designated preferred name (PT) | NO | |
RxCUI: 2608466 | B*4005 | Full form of descriptor (FN) | NO | |
RxCUI: 2608467 | B*4101 | Designated preferred name (PT) | NO | |
RxCUI: 2608467 | B*4101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608468 | B*4201 | Designated preferred name (PT) | NO | |
RxCUI: 2608468 | B*4201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608469 | B*4401 | Designated preferred name (PT) | NO | |
RxCUI: 2608469 | B*4401 | Full form of descriptor (FN) | NO | |
RxCUI: 260847 | Bufferin 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260847 | Bufferin 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260847 | Bufferin 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260847 | Bufferin 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608470 | B*4402 | Designated preferred name (PT) | NO | |
RxCUI: 2608470 | B*4402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608471 | B*4403 | Designated preferred name (PT) | NO | |
RxCUI: 2608471 | B*4403 | Full form of descriptor (FN) | NO | |
RxCUI: 2608472 | B*4501 | Designated preferred name (PT) | NO | |
RxCUI: 2608472 | B*4501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608473 | B*4601 | Designated preferred name (PT) | NO | |
RxCUI: 2608473 | B*4601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608474 | B*4701 | Designated preferred name (PT) | NO | |
RxCUI: 2608474 | B*4701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608475 | B*4801 | Designated preferred name (PT) | NO | |
RxCUI: 2608475 | B*4801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608476 | B*4901 | Designated preferred name (PT) | NO | |
RxCUI: 2608476 | B*4901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608477 | B*5001 | Designated preferred name (PT) | NO | |
RxCUI: 2608477 | B*5001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608478 | B*5101 | Designated preferred name (PT) | NO | |
RxCUI: 2608478 | B*5101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608479 | B*5103 | Designated preferred name (PT) | NO | |
RxCUI: 2608479 | B*5103 | Full form of descriptor (FN) | NO | |
RxCUI: 260848 | aspirin 325 MG Oral Tablet [Buffex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260848 | aspirin 325 MG Oral Tablet [Buffex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260848 | aspirin 325 MG Oral Tablet [Buffex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608480 | B*5201 | Designated preferred name (PT) | NO | |
RxCUI: 2608480 | B*5201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608481 | B*5301 | Designated preferred name (PT) | NO | |
RxCUI: 2608481 | B*5301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608482 | B*5401 | Designated preferred name (PT) | NO | |
RxCUI: 2608482 | B*5401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608483 | B*5501 | Designated preferred name (PT) | NO | |
RxCUI: 2608483 | B*5501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608484 | B*5601 | Designated preferred name (PT) | NO | |
RxCUI: 2608484 | B*5601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608485 | B*5602 | Designated preferred name (PT) | NO | |
RxCUI: 2608485 | B*5602 | Full form of descriptor (FN) | NO | |
RxCUI: 2608486 | B*5701 | Designated preferred name (PT) | NO | |
RxCUI: 2608486 | B*5701 | Full form of descriptor (FN) | NO | |
RxCUI: 2608487 | B*5702 | Designated preferred name (PT) | NO | |
RxCUI: 2608487 | B*5702 | Full form of descriptor (FN) | NO | |
RxCUI: 2608488 | B*5801 | Designated preferred name (PT) | NO | |
RxCUI: 2608488 | B*5801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608489 | B*7801 | Designated preferred name (PT) | NO | |
RxCUI: 2608489 | B*7801 | Full form of descriptor (FN) | NO | |
RxCUI: 260849 | aspirin 325 MG Oral Tablet [Uni-Buff] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260849 | aspirin 325 MG Oral Tablet [Uni-Buff] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260849 | aspirin 325 MG Oral Tablet [Uni-Buff] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608490 | B*7901 | Designated preferred name (PT) | NO | |
RxCUI: 2608490 | B*7901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608491 | A*0101 | Designated preferred name (PT) | NO | |
RxCUI: 2608491 | A*0101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608492 | A*0201 | Designated preferred name (PT) | NO | |
RxCUI: 2608492 | A*0201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608493 | A*0202 | Designated preferred name (PT) | NO | |
RxCUI: 2608493 | A*0202 | Full form of descriptor (FN) | NO | |
RxCUI: 2608494 | A*0203 | Designated preferred name (PT) | NO | |
RxCUI: 2608494 | A*0203 | Full form of descriptor (FN) | NO | |
RxCUI: 2608495 | A*0204 | Designated preferred name (PT) | NO | |
RxCUI: 2608495 | A*0204 | Full form of descriptor (FN) | NO | |
RxCUI: 2608496 | A*0205 | Designated preferred name (PT) | NO | |
RxCUI: 2608496 | A*0205 | Full form of descriptor (FN) | NO | |
RxCUI: 2608497 | A*0206 | Designated preferred name (PT) | NO | |
RxCUI: 2608497 | A*0206 | Full form of descriptor (FN) | NO | |
RxCUI: 2608498 | A*0207 | Designated preferred name (PT) | NO | |
RxCUI: 2608498 | A*0207 | Full form of descriptor (FN) | NO | |
RxCUI: 2608499 | A*0208 | Designated preferred name (PT) | NO | |
RxCUI: 2608499 | A*0208 | Full form of descriptor (FN) | NO | |
RxCUI: 2608500 | A*0209 | Designated preferred name (PT) | NO | |
RxCUI: 2608500 | A*0209 | Full form of descriptor (FN) | NO | |
RxCUI: 2608501 | A*0210 | Designated preferred name (PT) | NO | |
RxCUI: 2608501 | A*0210 | Full form of descriptor (FN) | NO | |
RxCUI: 2608502 | A*0211 | Designated preferred name (PT) | NO | |
RxCUI: 2608502 | A*0211 | Full form of descriptor (FN) | NO | |
RxCUI: 2608503 | A*0212 | Designated preferred name (PT) | NO | |
RxCUI: 2608503 | A*0212 | Full form of descriptor (FN) | NO | |
RxCUI: 2608504 | A*0301 | Designated preferred name (PT) | NO | |
RxCUI: 2608504 | A*0301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608505 | A*0302 | Designated preferred name (PT) | NO | |
RxCUI: 2608505 | A*0302 | Full form of descriptor (FN) | NO | |
RxCUI: 2608506 | A*1101 | Designated preferred name (PT) | NO | |
RxCUI: 2608506 | A*1101 | Full form of descriptor (FN) | NO | |
RxCUI: 2608507 | A*1102 | Designated preferred name (PT) | NO | |
RxCUI: 2608507 | A*1102 | Full form of descriptor (FN) | NO | |
RxCUI: 2608508 | A*2301 | Designated preferred name (PT) | NO | |
RxCUI: 2608508 | A*2301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608509 | A*2401 | Designated preferred name (PT) | NO | |
RxCUI: 2608509 | A*2401 | Full form of descriptor (FN) | NO | |
RxCUI: 260851 | aspirin 325 MG Delayed Release Oral Tablet [Genacote] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260851 | aspirin 325 MG Delayed Release Oral Tablet [Genacote] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260851 | aspirin 325 MG Delayed Release Oral Tablet [Genacote] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608510 | A*2501 | Designated preferred name (PT) | NO | |
RxCUI: 2608510 | A*2501 | Full form of descriptor (FN) | NO | |
RxCUI: 2608511 | A*2601 | Designated preferred name (PT) | NO | |
RxCUI: 2608511 | A*2601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608512 | A*2901 | Designated preferred name (PT) | NO | |
RxCUI: 2608512 | A*2901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608513 | A*2902 | Designated preferred name (PT) | NO | |
RxCUI: 2608513 | A*2902 | Full form of descriptor (FN) | NO | |
RxCUI: 2608514 | A*3001 | Designated preferred name (PT) | NO | |
RxCUI: 2608514 | A*3001 | Full form of descriptor (FN) | NO | |
RxCUI: 2608515 | A*3002 | Designated preferred name (PT) | NO | |
RxCUI: 2608515 | A*3002 | Full form of descriptor (FN) | NO | |
RxCUI: 2608516 | A*31011 | Designated preferred name (PT) | NO | |
RxCUI: 2608516 | A*31011 | Full form of descriptor (FN) | NO | |
RxCUI: 2608517 | A*31012 | Designated preferred name (PT) | NO | |
RxCUI: 2608517 | A*31012 | Full form of descriptor (FN) | NO | |
RxCUI: 2608518 | A*3201 | Designated preferred name (PT) | NO | |
RxCUI: 2608518 | A*3201 | Full form of descriptor (FN) | NO | |
RxCUI: 2608519 | A*3301 | Designated preferred name (PT) | NO | |
RxCUI: 2608519 | A*3301 | Full form of descriptor (FN) | NO | |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 260852 | Slo-Niacin 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608520 | A*3401 | Designated preferred name (PT) | NO | |
RxCUI: 2608520 | A*3401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608521 | A*3402 | Designated preferred name (PT) | NO | |
RxCUI: 2608521 | A*3402 | Full form of descriptor (FN) | NO | |
RxCUI: 2608522 | A*3601 | Designated preferred name (PT) | NO | |
RxCUI: 2608522 | A*3601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608523 | A*4301 | Designated preferred name (PT) | NO | |
RxCUI: 2608523 | A*4301 | Full form of descriptor (FN) | NO | |
RxCUI: 2608524 | A*6601 | Designated preferred name (PT) | NO | |
RxCUI: 2608524 | A*6601 | Full form of descriptor (FN) | NO | |
RxCUI: 2608525 | A*6602 | Designated preferred name (PT) | NO | |
RxCUI: 2608525 | A*6602 | Full form of descriptor (FN) | NO | |
RxCUI: 2608526 | A*6801 | Designated preferred name (PT) | NO | |
RxCUI: 2608526 | A*6801 | Full form of descriptor (FN) | NO | |
RxCUI: 2608527 | A*6802 | Designated preferred name (PT) | NO | |
RxCUI: 2608527 | A*6802 | Full form of descriptor (FN) | NO | |
RxCUI: 2608528 | A*6901 | Designated preferred name (PT) | NO | |
RxCUI: 2608528 | A*6901 | Full form of descriptor (FN) | NO | |
RxCUI: 2608529 | A*7401 | Designated preferred name (PT) | NO | |
RxCUI: 2608529 | A*7401 | Full form of descriptor (FN) | NO | |
RxCUI: 2608530 | PLD1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2608530 | PLD1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608531 | roflumilast 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2608532 | roflumilast Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2608533 | roflumilast Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2608534 | roflumilast 0.3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608534 | roflumilast 0.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608534 | roflumilast 0.3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608535 | Zoryve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2608536 | roflumilast 3 MG/ML [Zoryve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2608537 | Zoryve Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2608538 | roflumilast Topical Cream [Zoryve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2608539 | ZORYVE 0.3 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2608539 | ZORYVE 0.3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608539 | ZORYVE 0.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608539 | ZORYVE 0.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608540 | Abacavir (as abacavir sulfate) 120 mg and lamivudine 60 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2608540 | Abacavir (as abacavir sulfate) 120 mg and lamivudine 60 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608540 | Abacavir (as abacavir sulfate) 120 mg and lamivudine 60 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2608541 | Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2608541 | Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608541 | Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2608543 | Aceclofenac 200 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2608543 | Aceclofenac 200 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2608544 | Paracetamol 100 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2608544 | Paracetamol 100 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608544 | Paracetamol 100 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2608545 | Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2608545 | Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608545 | Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2608546 | Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2608546 | Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608546 | Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2608547 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion and/or injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608547 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608547 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608548 | Adenosine 3 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608548 | Adenosine 3 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608549 | Albumin human 200 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608549 | Albumin human 200 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608550 | Albumin human 250 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608550 | Albumin human 250 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608551 | Albumin human 50 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608551 | Albumin human 50 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608552 | Alteplase 2 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608552 | Alteplase 2 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608553 | Artemether 80 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608553 | Artemether 80 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608554 | Ceftriaxone (as ceftriaxone sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608554 | Ceftriaxone (as ceftriaxone sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 260858 | activated charcoal 25000 MG Oral Suspension [Charcoaid 2000] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260858 | activated charcoal 25000 MG Oral Suspension [Charcoaid 2000] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608655 | magnesium citrate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608655 | magnesium citrate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608656 | 27-norcholestanehexol | Designated preferred name (PT) | NO | |
RxCUI: 2608656 | 27-norcholestanehexol | Full form of descriptor (FN) | NO | |
RxCUI: 2608658 | High mobility group AT-hook protein 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608658 | High mobility group AT-hook protein 2 | Designated preferred name (PT) | NO | |
RxCUI: 2608658 | High mobility group AT-hook protein 2 | Full form of descriptor (FN) | NO | |
RxCUI: 2608659 | Human leucocyte antigen A allele | British preferred term (PTGB) | NO | |
RxCUI: 2608659 | Human leucocyte antigen A allele | Designated preferred name (PT) | NO | |
RxCUI: 2608659 | Human leucocyte antigen A allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608660 | Human leucocyte antigen B allele | British preferred term (PTGB) | NO | |
RxCUI: 2608660 | Human leucocyte antigen B allele | Designated preferred name (PT) | NO | |
RxCUI: 2608660 | Human leucocyte antigen B allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608661 | Human leucocyte antigen C allele | British preferred term (PTGB) | NO | |
RxCUI: 2608661 | Human leucocyte antigen C allele | Designated preferred name (PT) | NO | |
RxCUI: 2608661 | Human leucocyte antigen C allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608662 | Human leucocyte antigen DPA1 allele | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608662 | Human leucocyte antigen DPA1 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608662 | Human leucocyte antigen DPA1 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608663 | Human leucocyte antigen DPB1 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608663 | Human leucocyte antigen DPB1 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608663 | Human leucocyte antigen DPB1 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608664 | Human leucocyte antigen DQA1 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608664 | Human leucocyte antigen DQA1 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608664 | Human leucocyte antigen DQA1 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608665 | Human leucocyte antigen DQB1 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608665 | Human leucocyte antigen DQB1 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608665 | Human leucocyte antigen DQB1 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608666 | Human leucocyte antigen DRB1 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608666 | Human leucocyte antigen DRB1 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608666 | Human leucocyte antigen DRB1 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608667 | Human leucocyte antigen DRB3 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608667 | Human leucocyte antigen DRB3 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608667 | Human leucocyte antigen DRB3 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608668 | Human leucocyte antigen DRB4 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608668 | Human leucocyte antigen DRB4 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608668 | Human leucocyte antigen DRB4 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608669 | Human leucocyte antigen DRB5 allele | British preferred term (PTGB) | NO | |
RxCUI: 2608669 | Human leucocyte antigen DRB5 allele | Designated preferred name (PT) | NO | |
RxCUI: 2608669 | Human leucocyte antigen DRB5 allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608670 | Human leucocyte antigen allele | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608670 | Human leucocyte antigen allele | Designated preferred name (PT) | NO | |
RxCUI: 2608670 | Human leucocyte antigen allele | Full form of descriptor (FN) | NO | |
RxCUI: 2608671 | Ornithine oxoglurate monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608671 | Ornithine oxoglurate monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608672 | Paracetamol 1 g powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608672 | Paracetamol 1 g powder for oral solution sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608672 | Paracetamol 1 g powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608673 | Paracetamol 500 mg powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608673 | Paracetamol 500 mg powder for oral solution sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608673 | Paracetamol 500 mg powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608674 | Paracetamol 600 mg powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608674 | Paracetamol 600 mg powder for oral solution sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608674 | Paracetamol 600 mg powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608675 | Artesunate 20 mg and pyronaridine tetraphosphate 60 mg granules for oral suspension sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608675 | Artesunate 20 mg and pyronaridine tetraphosphate 60 mg granules for oral suspension sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608676 | Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608676 | Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608677 | Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608677 | Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608678 | Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608678 | Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608679 | Morphine sulfate 100 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608679 | Morphine sulfate 100 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608680 | Morphine sulfate 20 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608680 | Morphine sulfate 20 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608681 | Morphine sulfate 200 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608681 | Morphine sulfate 200 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608682 | Morphine sulfate 30 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608682 | Morphine sulfate 30 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608683 | Morphine sulfate 60 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608683 | Morphine sulfate 60 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608684 | Para-aminosalicylic acid 4 g gastro-resistant oral granules sachet | Designated preferred name (PT) | NO | |
RxCUI: 2608684 | Para-aminosalicylic acid 4 g gastro-resistant oral granules sachet | Full form of descriptor (FN) | NO | |
RxCUI: 2608686 | Atorvastatin (as atorvastatin calcium) 10 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2608686 | Atorvastatin (as atorvastatin calcium) 10 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2608687 | Clarithromycin (as clarithromycin lactobionate) 500 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2608687 | Clarithromycin (as clarithromycin lactobionate) 500 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608688 | Barium sulfate 1 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2608688 | Barium sulfate 1 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2608689 | Barium sulfate 240 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2608689 | Barium sulfate 240 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2608690 | Barium sulfate 49 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2608690 | Barium sulfate 49 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2608691 | Barium sulfate 600 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2608691 | Barium sulfate 600 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2608693 | Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2608693 | Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2608694 | Lopinavir 40 mg and ritonavir 10 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2608694 | Lopinavir 40 mg and ritonavir 10 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2608695 | Finzala 24 Fe Chewable 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2608695 | Finzala 24 Fe Chewable 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608695 | Finzala 24 Fe Chewable 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608696 | midazolam 14.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2608697 | midazolam Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2608698 | midazolam 10 MG in 0.7 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2608698 | midazolam 10 MG in 0.7 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2608698 | midazolam 10 MG in 0.7 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608699 | midazolam 14.3 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2608702 | Amikacin (as amikacin sulfate) 250 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608702 | Amikacin (as amikacin sulfate) 250 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608703 | Haloperidol (as haloperidol decanoate) 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608703 | Haloperidol (as haloperidol decanoate) 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608704 | Haloperidol (as haloperidol decanoate) 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608704 | Haloperidol (as haloperidol decanoate) 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608705 | Cefotaxime (as cefotaxime sodium) 250 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608705 | Cefotaxime (as cefotaxime sodium) 250 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608706 | Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608706 | Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608707 | Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608707 | Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608708 | Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608708 | Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608713 | Brolucizumab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608713 | Brolucizumab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608714 | Cetuximab 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608714 | Cetuximab 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608715 | Lanreotide (as lanreotide acetate) 180 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608715 | Lanreotide (as lanreotide acetate) 180 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608716 | Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608716 | Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608717 | Sodium hyaluronate 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608717 | Sodium hyaluronate 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608717 | Sodium hyaluronate 10 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608718 | Ifosfamide 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608718 | Ifosfamide 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608719 | Azathioprine (as azathioprine sodium) 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608719 | Azathioprine (as azathioprine sodium) 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608721 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608721 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608722 | Cloxacillin (as cloxacillin sodium) 10 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608722 | Cloxacillin (as cloxacillin sodium) 10 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608723 | Dobutamine (as dobutamine hydrochloride) 12.5 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608723 | Dobutamine (as dobutamine hydrochloride) 12.5 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608724 | Dopamine hydrochloride 40 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608724 | Dopamine hydrochloride 40 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608725 | Doxorubicin hydrochloride 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608725 | Doxorubicin hydrochloride 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608726 | Insulin detemir 100 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608726 | Insulin detemir 100 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608727 | Insulin glargine 300 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608727 | Insulin glargine 300 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608728 | Interferon beta-1a 44 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608728 | Interferon beta-1a 44 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608730 | Interferon beta-1a 88 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608730 | Interferon beta-1a 88 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608736 | Ipilimumab 5 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608736 | Ipilimumab 5 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608737 | Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608737 | Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608739 | Iron (as ferric derisomaltose) 100 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608739 | Iron (as ferric derisomaltose) 100 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608740 | Iron (as iron sucrose) 20 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608740 | Iron (as iron sucrose) 20 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608741 | Epirubicin hydrochloride 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608741 | Epirubicin hydrochloride 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608742 | Erythromycin (as erythromycin lactobionate) 1 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608742 | Erythromycin (as erythromycin lactobionate) 1 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608743 | Lanadelumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608743 | Lanadelumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608744 | Lanreotide (as lanreotide acetate) 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608744 | Lanreotide (as lanreotide acetate) 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608745 | Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608745 | Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608746 | Etanercept 10 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608746 | Etanercept 10 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608747 | Etofylline 84.7 mg/mL and theophylline anhydrous 25.3 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608747 | Etofylline 84.7 mg/mL and theophylline anhydrous 25.3 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608748 | Zanamivir hydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608748 | Zanamivir hydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608749 | Folinic acid (as calcium folinate) 3 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608749 | Folinic acid (as calcium folinate) 3 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608749 | Folinic acid (as calcium folinate) 3 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608750 | Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608750 | Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608751 | Leuprorelin acetate 60 mg/mL suspension for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608751 | Leuprorelin acetate 60 mg/mL suspension for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608751 | Leuprorelin acetate 60 mg/mL suspension for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608752 | Levofloxacin 5 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608752 | Levofloxacin 5 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608753 | Linezolid 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608753 | Linezolid 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608754 | Fluconazole 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608754 | Fluconazole 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608755 | Mannitol 100 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608755 | Mannitol 100 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608756 | Mannitol 200 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608756 | Mannitol 200 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608757 | Melarsoprol 36 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608757 | Melarsoprol 36 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608758 | Daratumumab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608758 | Daratumumab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608759 | Human anti-D immunoglobulin 1136.364 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608759 | Human anti-D immunoglobulin 1136.364 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608760 | Fluorouracil (as fluorouracil sodium) 50 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608760 | Fluorouracil (as fluorouracil sodium) 50 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608761 | Carboprost (as carboprost trometamol) 125 microgram/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608761 | Carboprost (as carboprost trometamol) 125 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608761 | Carboprost (as carboprost trometamol) 125 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608762 | Cefoperazone (as cefoperazone sodium) 500 mg and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608762 | Cefoperazone (as cefoperazone sodium) 500 mg and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608763 | Soya bean oil refined 100 mg/mL emulsion for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608763 | Soya bean oil refined 100 mg/mL emulsion for infusion and/or injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608763 | Soya bean oil refined 100 mg/mL emulsion for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608764 | Soya bean oil refined 200 mg/mL emulsion for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608764 | Soya bean oil refined 200 mg/mL emulsion for infusion and/or injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608764 | Soya bean oil refined 200 mg/mL emulsion for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608765 | Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608765 | Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608766 | Foscarnet sodium 24 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608766 | Foscarnet sodium 24 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608767 | Carbazochrome 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608767 | Carbazochrome 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608768 | Glucagon 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608768 | Glucagon 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608769 | Glucose 100 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608769 | Glucose 100 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608770 | Glucose 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608770 | Glucose 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608771 | Glucose 50 mg/mL and sodium chloride 4.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608771 | Glucose 50 mg/mL and sodium chloride 4.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608772 | Glucose 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608772 | Glucose 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608773 | Glucose 500 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608773 | Glucose 500 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608774 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608774 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608775 | Sodium valproate 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608775 | Sodium valproate 100 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608775 | Sodium valproate 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608776 | Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608776 | Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608777 | Botulinum toxin type A 50 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608777 | Botulinum toxin type A 50 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608778 | Botulinum toxin type A 100 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608778 | Botulinum toxin type A 100 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608779 | Botulinum toxin type A 125 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608779 | Botulinum toxin type A 125 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608780 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608780 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608780 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608781 | Follitropin delta 33.333 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608781 | Follitropin delta 33.333 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608782 | Product containing precisely suramin sodium 1 gram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608782 | Product containing precisely suramin sodium 1 gram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608783 | Galcanezumab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608783 | Galcanezumab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608785 | Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608785 | Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608786 | Iodine (as ethiodised oil) 480 mg/mL solution for injection | British preferred term (PTGB) | NO | |
RxCUI: 2608786 | Iodine (as ethiodised oil) 480 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608786 | Iodine (as ethiodised oil) 480 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608787 | Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608787 | Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608788 | Hexastarch 60 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608788 | Hexastarch 60 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608789 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608789 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608790 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608790 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608791 | Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608791 | Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608792 | Potassium chloride 1.5 mg/mL and sodium chloride 9 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608792 | Potassium chloride 1.5 mg/mL and sodium chloride 9 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608838 | Amoxicillin (as amoxicillin sodium) 250 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608838 | Amoxicillin (as amoxicillin sodium) 250 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608839 | Amikacin (as amikacin sulfate) 125 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608839 | Amikacin (as amikacin sulfate) 125 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608840 | Flucloxacillin (as flucloxacillin sodium) 2 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608840 | Flucloxacillin (as flucloxacillin sodium) 2 g powder for solution for infusion and/or injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608840 | Flucloxacillin (as flucloxacillin sodium) 2 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608841 | Potassium chloride 112 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608841 | Potassium chloride 112 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608842 | Potassium chloride 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608842 | Potassium chloride 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608843 | Potassium chloride 74.6 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608843 | Potassium chloride 74.6 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608844 | Parecoxib (as parecoxib sodium) 40 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608844 | Parecoxib (as parecoxib sodium) 40 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608845 | Normal human immunoglobulin 160 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608845 | Normal human immunoglobulin 160 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608846 | Human fibrinogen 1 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608846 | Human fibrinogen 1 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608847 | Human tetanus immunoglobulin 100 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608847 | Human tetanus immunoglobulin 100 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608848 | Cefuroxime (as cefuroxime sodium) 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608848 | Cefuroxime (as cefuroxime sodium) 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608849 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608849 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608850 | Cloxacillin (as cloxacillin sodium) 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608850 | Cloxacillin (as cloxacillin sodium) 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608851 | Artesunate 60 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608851 | Artesunate 60 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608852 | Potassium chloride 2 mg/mL and sodium chloride 9 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
RxCUI: 2608852 | Potassium chloride 2 mg/mL and sodium chloride 9 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608853 | Glucose 75 mg/mL and lidocaine hydrochloride 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2608853 | Glucose 75 mg/mL and lidocaine hydrochloride 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2608854 | Coagulation factor VIII 1000 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608854 | Coagulation factor VIII 1000 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608855 | Coagulation factor VIII 250 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608855 | Coagulation factor VIII 250 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608856 | Coagulation factor VIII 500 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2608856 | Coagulation factor VIII 500 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2608944 | Cefepime hydrochloride monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608944 | Cefepime hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608946 | 2,4,5-T triethylammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2608947 | bortezomib 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2608948 | bortezomib 3.5 MG in 1.4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608948 | bortezomib 3.5 MG in 1.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608948 | bortezomib 3.5 MG in 1.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608949 | bortezomib 2.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2608951 | bortezomib 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2608952 | bortezomib 3.5 MG in 3.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2608952 | bortezomib 3.5 MG in 3.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2608952 | bortezomib 3.5 MG in 3.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2608953 | bortezomib 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2608954 | Halothane 1 mL/mL solution for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2608954 | Halothane 1 mL/mL solution for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2608955 | Ceftaroline fosamil acetic acid solvate | Designated preferred name (PT) | NO | |
RxCUI: 2608955 | Ceftaroline fosamil acetic acid solvate | Full form of descriptor (FN) | NO | |
RxCUI: 2608956 | Dasatinib monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608956 | Dasatinib monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608957 | Desmopressin acetate trihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608957 | Desmopressin acetate trihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608958 | Diclofenac sodium 40 mg/g cutaneous spray | Designated preferred name (PT) | NO | |
RxCUI: 2608958 | Diclofenac sodium 40 mg/g cutaneous spray | Full form of descriptor (FN) | NO | |
RxCUI: 2608962 | Permethrin 10 mg/g cutaneous solution | Designated preferred name (PT) | NO | |
RxCUI: 2608962 | Permethrin 10 mg/g cutaneous solution | Full form of descriptor (FN) | NO | |
RxCUI: 2608963 | Pholcodine monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608963 | Pholcodine monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608964 | Lidocaine hydrochloride monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608964 | Lidocaine hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608965 | Liver enzyme | Designated preferred name (PT) | NO | |
RxCUI: 2608965 | Liver enzyme | Full form of descriptor (FN) | NO | |
RxCUI: 2608966 | Blood group antigen K2 | Designated preferred name (PT) | NO | |
RxCUI: 2608966 | Blood group antigen K2 | Full form of descriptor (FN) | NO | |
RxCUI: 2608966 | Blood group antigen K2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608966 | Blood group antigen K2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608966 | Blood group antigen K2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608966 | Blood group antigen K2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608967 | Medical food | Designated preferred name (PT) | NO | |
RxCUI: 2608967 | Medical food | Full form of descriptor (FN) | NO | |
RxCUI: 2608968 | Medical beverage | Designated preferred name (PT) | NO | |
RxCUI: 2608968 | Medical beverage | Full form of descriptor (FN) | NO | |
RxCUI: 2608969 | Surface lambda | Designated preferred name (PT) | NO | |
RxCUI: 2608969 | Surface lambda | Full form of descriptor (FN) | NO | |
RxCUI: 2608970 | Surface kappa | Designated preferred name (PT) | NO | |
RxCUI: 2608970 | Surface kappa | Full form of descriptor (FN) | NO | |
RxCUI: 2608971 | Surface epsilon | Designated preferred name (PT) | NO | |
RxCUI: 2608971 | Surface epsilon | Full form of descriptor (FN) | NO | |
RxCUI: 2608972 | Surface alpha | Designated preferred name (PT) | NO | |
RxCUI: 2608972 | Surface alpha | Full form of descriptor (FN) | NO | |
RxCUI: 2608973 | Surface gamma | Designated preferred name (PT) | NO | |
RxCUI: 2608973 | Surface gamma | Full form of descriptor (FN) | NO | |
RxCUI: 2608974 | Surface delta | Designated preferred name (PT) | NO | |
RxCUI: 2608974 | Surface delta | Full form of descriptor (FN) | NO | |
RxCUI: 2608975 | Surface mu | Designated preferred name (PT) | NO | |
RxCUI: 2608975 | Surface mu | Full form of descriptor (FN) | NO | |
RxCUI: 2608976 | Surface immunoglobulin marker | Designated preferred name (PT) | NO | |
RxCUI: 2608976 | Surface immunoglobulin marker | Full form of descriptor (FN) | NO | |
RxCUI: 2608978 | Cardiac enzyme | Designated preferred name (PT) | NO | |
RxCUI: 2608978 | Cardiac enzyme | Full form of descriptor (FN) | NO | |
RxCUI: 2608979 | Steak and kidney pie | Designated preferred name (PT) | NO | |
RxCUI: 2608979 | Steak and kidney pie | Full form of descriptor (FN) | NO | |
RxCUI: 2608980 | Grilled veal | Designated preferred name (PT) | NO | |
RxCUI: 2608980 | Grilled veal | Full form of descriptor (FN) | NO | |
RxCUI: 2608981 | Fried veal | Designated preferred name (PT) | NO | |
RxCUI: 2608981 | Fried veal | Full form of descriptor (FN) | NO | |
RxCUI: 2608982 | Veal | Designated preferred name (PT) | NO | |
RxCUI: 2608982 | Veal | Full form of descriptor (FN) | NO | |
RxCUI: 2608983 | Stewed beef | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608983 | Stewed beef | Designated preferred name (PT) | NO | |
RxCUI: 2608983 | Stewed beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608984 | Lean roast beef | Designated preferred name (PT) | NO | |
RxCUI: 2608984 | Lean roast beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608985 | Roast beef | Designated preferred name (PT) | NO | |
RxCUI: 2608985 | Roast beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608986 | Stewed extra-lean minced beef | Designated preferred name (PT) | NO | |
RxCUI: 2608986 | Stewed extra-lean minced beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608987 | Stewed minced beef | Designated preferred name (PT) | NO | |
RxCUI: 2608987 | Stewed minced beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608988 | Minced beef | Designated preferred name (PT) | NO | |
RxCUI: 2608988 | Minced beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608989 | Boiled salt beef | Designated preferred name (PT) | NO | |
RxCUI: 2608989 | Boiled salt beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608990 | Boiled beef | Designated preferred name (PT) | NO | |
RxCUI: 2608990 | Boiled beef | Full form of descriptor (FN) | NO | |
RxCUI: 2608991 | Fried beef steak | Designated preferred name (PT) | NO | |
RxCUI: 2608991 | Fried beef steak | Full form of descriptor (FN) | NO | |
RxCUI: 2608992 | Grilled beef steak | Designated preferred name (PT) | NO | |
RxCUI: 2608992 | Grilled beef steak | Full form of descriptor (FN) | NO | |
RxCUI: 2608993 | Beef steak | Designated preferred name (PT) | NO | |
RxCUI: 2608993 | Beef steak | Full form of descriptor (FN) | NO | |
RxCUI: 2608994 | Omeprazole 10 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2608994 | Omeprazole 10 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2608995 | Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2608995 | Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2608996 | Venous cord blood | Designated preferred name (PT) | NO | |
RxCUI: 2608996 | Venous cord blood | Full form of descriptor (FN) | NO | |
RxCUI: 2608997 | Valaciclovir hydrochloride dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608997 | Valaciclovir hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608998 | Upadacitinib hemihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2608998 | Upadacitinib hemihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2608999 | BRCA1-associated protein 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2608999 | BRCA1-associated protein 1 | Designated preferred name (PT) | NO | |
RxCUI: 2608999 | BRCA1-associated protein 1 | Full form of descriptor (FN) | NO | |
RxCUI: 2609002 | Terazosin hydrochloride dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609002 | Terazosin hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609004 | Aprepitant 165 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2609004 | Aprepitant 165 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2609005 | 5-hydroxytryptophan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2609006 | 5-hydroxytryptophan 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609006 | 5-hydroxytryptophan 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609009 | Duloxetine (as duloxetine hydrochloride) 20 mg and mecobalamin 1.5 mg gastro-resistant oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2609009 | Duloxetine (as duloxetine hydrochloride) 20 mg and mecobalamin 1.5 mg gastro-resistant oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2609010 | Substance with androgen receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 2609010 | Substance with androgen receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609010 | Substance with androgen receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 2609011 | Substance with steroid structure and androgen receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 2609011 | Substance with steroid structure and androgen receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609011 | Substance with steroid structure and androgen receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 2609013 | T-cell receptor excision circle | Designated preferred name (PT) | NO | |
RxCUI: 2609013 | T-cell receptor excision circle | Full form of descriptor (FN) | NO | |
RxCUI: 2609015 | T-cell receptor marker | Designated preferred name (PT) | NO | |
RxCUI: 2609015 | T-cell receptor marker | Full form of descriptor (FN) | NO | |
RxCUI: 2609016 | Proto-oncogene B-Raf | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609016 | Proto-oncogene B-Raf | Designated preferred name (PT) | NO | |
RxCUI: 2609016 | Proto-oncogene B-Raf | Full form of descriptor (FN) | NO | |
RxCUI: 2609016 | Proto-oncogene B-Raf | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609018 | Proto-oncogene c-Ros-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609018 | Proto-oncogene c-Ros-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609018 | Proto-oncogene c-Ros-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609018 | Proto-oncogene c-Ros-1 | Designated preferred name (PT) | NO | |
RxCUI: 2609018 | Proto-oncogene c-Ros-1 | Full form of descriptor (FN) | NO | |
RxCUI: 2609027 | Dinoprostone 10 mg prolonged-release vaginal delivery system | Designated preferred name (PT) | NO | |
RxCUI: 2609027 | Dinoprostone 10 mg prolonged-release vaginal delivery system | Full form of descriptor (FN) | NO | |
RxCUI: 2609029 | Domperidone 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2609029 | Domperidone 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2609031 | Itopride hydrochloride 150 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2609031 | Itopride hydrochloride 150 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2609034 | Nicotine 1.563 mg/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
RxCUI: 2609034 | Nicotine 1.563 mg/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
RxCUI: 2609035 | Product containing precisely progesterone 416.667 microgram/1 hour prolonged-release vaginal ring (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609035 | Product containing precisely progesterone 416.667 microgram/1 hour prolonged-release vaginal ring (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609036 | Putative postmeiotic segregation increased 2-like protein 3 | Designated preferred name (PT) | NO | |
RxCUI: 2609036 | Putative postmeiotic segregation increased 2-like protein 3 | Full form of descriptor (FN) | NO | |
RxCUI: 2609039 | benzethonium chloride 0.2 % / benzocaine 15 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609039 | benzethonium chloride 0.2 % / benzocaine 15 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609039 | benzethonium chloride 0.2 % / benzocaine 15 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2609041 | Bombyx mori protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609041 | Bombyx mori protein | Full form of descriptor (FN) | NO | |
RxCUI: 2609041 | Bombyx mori protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609041 | Bombyx mori protein | Designated preferred name (PT) | NO | |
RxCUI: 2609043 | Product containing precisely retinol (as retinol palmitate) 100000 unit/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609043 | Product containing precisely retinol (as retinol palmitate) 100000 unit/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609044 | Product containing precisely retinol (as retinol palmitate) 100000 unit/1 milliliter conventional release oral drops (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609044 | Product containing precisely retinol (as retinol palmitate) 100000 unit/1 milliliter conventional release oral drops (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609045 | Product containing precisely retinol (as retinol palmitate) 200000 unit/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609045 | Product containing precisely retinol (as retinol palmitate) 200000 unit/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609046 | Product containing precisely retinol (as retinol palmitate) 50000 unit/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609046 | Product containing precisely retinol (as retinol palmitate) 50000 unit/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609047 | Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609047 | Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609048 | Dacarbazine (as dacarbazine citrate) 500 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609048 | Dacarbazine (as dacarbazine citrate) 500 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609049 | Clarithromycin lactobionate | Designated preferred name (PT) | NO | |
RxCUI: 2609049 | Clarithromycin lactobionate | Full form of descriptor (FN) | NO | |
RxCUI: 2609050 | Clodronate disodium tetrahydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609050 | Clodronate disodium tetrahydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609051 | Docetaxel 20 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
RxCUI: 2609051 | Docetaxel 20 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
RxCUI: 2609052 | Levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2609052 | Levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609052 | Levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
RxCUI: 2609052 | Levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609052 | Levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609053 | Estramustine phosphate sodium monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609053 | Estramustine phosphate sodium monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609054 | Aesculin sesquihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609054 | Aesculin sesquihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609054 | Aesculin sesquihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609054 | Aesculin sesquihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609058 | Choline theophyllinate 20 mg/mL and salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2609058 | Choline theophyllinate 20 mg/mL and salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609058 | Choline theophyllinate 20 mg/mL and salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609242 | allopurinol 200 MG [Zyloprim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609243 | ZYLOPRIM 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609243 | ZYLOPRIM 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609243 | ZYLOPRIM 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609244 | C30-45 alkyl cetearyl dimethicone crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2609245 | famotidine 20 MG [Zantac Reformulated Aug 2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609246 | Zantac 360 20 MG Oral Tablet, Reformulated Aug 2022 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609246 | Zantac 360 20 MG Oral Tablet, Reformulated Aug 2022 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609246 | Zantac 360 20 MG Oral Tablet, Reformulated Aug 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609246 | Zantac 360 20 MG Oral Tablet, Reformulated Aug 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609367 | Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609367 | Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609367 | Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609368 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609368 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609368 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609369 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 15 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609369 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 15 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609369 | Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 15 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609370 | Mefenamic acid 500 mg and paracetamol 325 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609370 | Mefenamic acid 500 mg and paracetamol 325 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609370 | Mefenamic acid 500 mg and paracetamol 325 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609371 | Acetylcysteine 150 mg and taurine 500 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609371 | Acetylcysteine 150 mg and taurine 500 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609372 | Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609372 | Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609372 | Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609375 | Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609375 | Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609375 | Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609377 | Aciclovir 200 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609377 | Aciclovir 200 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609377 | Aciclovir 200 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609377 | Aciclovir 200 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609377 | Aciclovir 200 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609378 | Activated charcoal 813 mg/g granules for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609378 | Activated charcoal 813 mg/g granules for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609379 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609379 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609379 | Aciclovir (as aciclovir sodium) 250 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609380 | camphor 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609380 | camphor 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609380 | camphor 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609381 | Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609381 | Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609382 | Alendronate sodium monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609382 | Alendronate sodium monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609383 | Alendronate sodium trihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609383 | Alendronate sodium trihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609384 | Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609384 | Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609385 | Alprostadil 3 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
RxCUI: 2609385 | Alprostadil 3 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
RxCUI: 2609386 | Aluminium oxide hydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609386 | Aluminium oxide hydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609387 | Pyrazinamide 150 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609387 | Pyrazinamide 150 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609387 | Pyrazinamide 150 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609388 | Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609388 | Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609388 | Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609389 | Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609389 | Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609389 | Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609390 | Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2609390 | Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609391 | Product containing precisely retinol (as retinol palmitate) 10000 unit/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609391 | Product containing precisely retinol (as retinol palmitate) 10000 unit/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609392 | Cefpodoxime (as cefpodoxime proxetil) 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609392 | Cefpodoxime (as cefpodoxime proxetil) 100 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609392 | Cefpodoxime (as cefpodoxime proxetil) 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609393 | Cefuroxime (as cefuroxime axetil) 125 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609393 | Cefuroxime (as cefuroxime axetil) 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609393 | Cefuroxime (as cefuroxime axetil) 125 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609394 | Cefuroxime (as cefuroxime axetil) 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609394 | Cefuroxime (as cefuroxime axetil) 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609395 | Cefalexin 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609395 | Cefalexin 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609395 | Cefalexin 125 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609395 | Cefalexin 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609395 | Cefalexin 125 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609396 | Amikacin sulfate 10 mg/mL eye drops | Designated preferred name (PT) | NO | |
RxCUI: 2609396 | Amikacin sulfate 10 mg/mL eye drops | Full form of descriptor (FN) | NO | |
RxCUI: 2609397 | Aminolevulinic acid hydrochloride (as 5-aminolevulinic acid) 30 mg/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2609397 | Aminolevulinic acid hydrochloride (as 5-aminolevulinic acid) 30 mg/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609398 | Cefalexin 250 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609398 | Cefalexin 250 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609398 | Cefalexin 250 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609398 | Cefalexin 250 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609398 | Cefalexin 250 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609399 | Cefalexin 500 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609399 | Cefalexin 500 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609399 | Cefalexin 500 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609399 | Cefalexin 500 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609399 | Cefalexin 500 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609400 | Chloroquine phosphate 160 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609400 | Chloroquine phosphate 160 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609401 | Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609401 | Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609402 | Ciprofloxacin (as ciprofloxacin hydrochloride) 250 mg and tinidazole 300 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609402 | Ciprofloxacin (as ciprofloxacin hydrochloride) 250 mg and tinidazole 300 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609403 | Dicycloverine hydrochloride 10 mg and mefenamic acid 250 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609403 | Dicycloverine hydrochloride 10 mg and mefenamic acid 250 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609403 | Dicycloverine hydrochloride 10 mg and mefenamic acid 250 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609404 | Diethylcarbamazine citrate 100 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609404 | Diethylcarbamazine citrate 100 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609405 | Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609405 | Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609405 | Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609406 | Hydrochlorothiazide 12.5 mg and nebivolol (as nebivolol hydrochloride) 5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609406 | Hydrochlorothiazide 12.5 mg and nebivolol (as nebivolol hydrochloride) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609407 | Nystatin 100000 unit oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609407 | Nystatin 100000 unit oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609408 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609408 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609408 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609409 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609409 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609409 | Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609410 | Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609410 | Atorvastatin (as atorvastatin calcium) 10 mg and fenofibrate 160 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609411 | Clonazepam 250 microgram tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609411 | Clonazepam 250 microgram tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609411 | Clonazepam 250 microgram tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609412 | Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609412 | Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609413 | Isoniazid 300 mg and pyridoxine hydrochloride 25 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609413 | Isoniazid 300 mg and pyridoxine hydrochloride 25 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609414 | Para-aminosalicylic acid 500 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609414 | Para-aminosalicylic acid 500 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609415 | Drotaverine hydrochloride 80 mg and mefenamic acid 250 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609415 | Drotaverine hydrochloride 80 mg and mefenamic acid 250 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609416 | Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609416 | Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609417 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609417 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609418 | Ivermectin 12 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609418 | Ivermectin 12 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609419 | Ivermectin 12 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609419 | Ivermectin 12 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609419 | Ivermectin 12 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609420 | Ketorolac trometamol 10 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609420 | Ketorolac trometamol 10 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609420 | Ketorolac trometamol 10 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609420 | Ketorolac trometamol 10 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609420 | Ketorolac trometamol 10 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609421 | Lamotrigine 100 mg chewable tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609421 | Lamotrigine 100 mg chewable tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609422 | Piroxicam 20 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609422 | Piroxicam 20 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609422 | Piroxicam 20 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609423 | Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609423 | Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609424 | Product containing precisely ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609424 | Product containing precisely ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609425 | Aciclovir 400 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609425 | Aciclovir 400 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609425 | Aciclovir 400 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609425 | Aciclovir 400 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609425 | Aciclovir 400 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609426 | Aciclovir 800 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609426 | Aciclovir 800 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609426 | Aciclovir 800 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609426 | Aciclovir 800 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609426 | Aciclovir 800 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609427 | Ethambutol 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609427 | Ethambutol 100 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609427 | Ethambutol 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609428 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609428 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609428 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609429 | Ethionamide 125 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609429 | Ethionamide 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609429 | Ethionamide 125 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609430 | Etofylline 77 mg and theophylline anhydrous 23 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609430 | Etofylline 77 mg and theophylline anhydrous 23 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609431 | Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609431 | Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609431 | Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609432 | Levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609432 | Levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609432 | Levamlodipine (as levamlodipine besilate) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609433 | Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609433 | Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609434 | Potassium permanganate 400 mg tablet for cutaneous solution | Designated preferred name (PT) | NO | |
RxCUI: 2609434 | Potassium permanganate 400 mg tablet for cutaneous solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609435 | Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609435 | Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609436 | Levofloxacin 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609436 | Levofloxacin 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609437 | Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609437 | Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609438 | Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609438 | Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609439 | Linezolid 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609439 | Linezolid 100 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609439 | Linezolid 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609440 | Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609440 | Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609441 | Amisulpride 100 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609441 | Amisulpride 100 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609442 | Amisulpride 200 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609442 | Amisulpride 200 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609443 | Etoricoxib 60 mg and thiocolchicoside 4 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609443 | Etoricoxib 60 mg and thiocolchicoside 4 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609444 | Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609444 | Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609445 | Amisulpride 400 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609445 | Amisulpride 400 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609446 | Amlodipine (as amlodipine besilate) 2.5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609446 | Amlodipine (as amlodipine besilate) 2.5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609446 | Amlodipine (as amlodipine besilate) 2.5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609447 | Amlodipine (as amlodipine besilate) 5 mg and atenolol 50 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609447 | Amlodipine (as amlodipine besilate) 5 mg and atenolol 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609447 | Amlodipine (as amlodipine besilate) 5 mg and atenolol 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609448 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609448 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609448 | Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609450 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609450 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609450 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609451 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609451 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609451 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609452 | Animal material diagnostic allergen extract | Designated preferred name (PT) | NO | |
RxCUI: 2609452 | Animal material diagnostic allergen extract | Full form of descriptor (FN) | NO | |
RxCUI: 2609453 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609453 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609453 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609454 | Amodiaquine (as amodiaquine hydrochloride) 135 mg and artesunate 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609454 | Amodiaquine (as amodiaquine hydrochloride) 135 mg and artesunate 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609455 | Arterial cord blood | Designated preferred name (PT) | NO | |
RxCUI: 2609455 | Arterial cord blood | Full form of descriptor (FN) | NO | |
RxCUI: 2609456 | Amodiaquine (as amodiaquine hydrochloride) 153 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609456 | Amodiaquine (as amodiaquine hydrochloride) 153 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609457 | Artesunate 100 mg rectal suppository | Designated preferred name (PT) | NO | |
RxCUI: 2609457 | Artesunate 100 mg rectal suppository | Full form of descriptor (FN) | NO | |
RxCUI: 2609458 | Amodiaquine (as amodiaquine hydrochloride) 270 mg and artesunate 100 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609458 | Amodiaquine (as amodiaquine hydrochloride) 270 mg and artesunate 100 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609459 | Amodiaquine (as amodiaquine hydrochloride) 67.5 mg and artesunate 25 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609459 | Amodiaquine (as amodiaquine hydrochloride) 67.5 mg and artesunate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609460 | Amodiaquine (as amodiaquine hydrochloride) 76.5 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609460 | Amodiaquine (as amodiaquine hydrochloride) 76.5 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609460 | Amodiaquine (as amodiaquine hydrochloride) 76.5 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609461 | Benznidazole 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609461 | Benznidazole 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609462 | Benzoxonium chloride 1 mg and lidocaine hydrochloride 1 mg chewable tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609462 | Benzoxonium chloride 1 mg and lidocaine hydrochloride 1 mg chewable tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609463 | Gabapentin 100 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609463 | Gabapentin 100 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609464 | Gabapentin 300 mg and mecobalamin 500 microgram oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609464 | Gabapentin 300 mg and mecobalamin 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609465 | Gabapentin 400 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609465 | Gabapentin 400 mg and nortriptyline (as nortriptyline hydrochloride) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609466 | Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609466 | Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609467 | Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609467 | Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609468 | Metoprolol tartrate (as metoprolol succinate) 50 mg and telmisartan 40 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609468 | Metoprolol tartrate (as metoprolol succinate) 50 mg and telmisartan 40 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609469 | Amoxicillin 200 mg and clavulanic acid (as clavulanate potassium) 28.5 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609469 | Amoxicillin 200 mg and clavulanic acid (as clavulanate potassium) 28.5 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 260947 | aluminum hydroxide 300 MG Oral Tablet [Amphojel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260947 | aluminum hydroxide 300 MG Oral Tablet [Amphojel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609470 | Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609470 | Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609471 | Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609471 | Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609472 | Artemether 20 mg and lumefantrine 120 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609472 | Artemether 20 mg and lumefantrine 120 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609472 | Artemether 20 mg and lumefantrine 120 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609473 | Artenimol 20 mg and piperaquine phosphate 160 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609473 | Artenimol 20 mg and piperaquine phosphate 160 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609474 | Artenimol 40 mg and piperaquine phosphate 320 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609474 | Artenimol 40 mg and piperaquine phosphate 320 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609475 | Artesunate 100 mg and mefloquine hydrochloride 220 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609475 | Artesunate 100 mg and mefloquine hydrochloride 220 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609476 | Artesunate 25 mg and mefloquine (as mefloquine hydrochloride) 50 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609476 | Artesunate 25 mg and mefloquine (as mefloquine hydrochloride) 50 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609477 | Artesunate 60 mg and pyronaridine tetraphosphate 180 mg oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609477 | Artesunate 60 mg and pyronaridine tetraphosphate 180 mg oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609478 | Cefixime 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609478 | Cefixime 100 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609478 | Cefixime 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609479 | Misoprostol 100 microgram vaginal tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609479 | Misoprostol 100 microgram vaginal tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609480 | Misoprostol 200 microgram vaginal tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609480 | Misoprostol 200 microgram vaginal tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609481 | Misoprostol 25 microgram vaginal tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609481 | Misoprostol 25 microgram vaginal tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609482 | Nevirapine 50 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609482 | Nevirapine 50 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609482 | Nevirapine 50 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609484 | Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609484 | Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609484 | Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609485 | Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609485 | Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609485 | Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609513 | Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
RxCUI: 2609513 | Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609513 | Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
RxCUI: 2609516 | Docetaxel 40 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
RxCUI: 2609516 | Docetaxel 40 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
RxCUI: 2609517 | Iodine (as ethiodised oil) 190 mg oral capsule | British preferred term (PTGB) | NO | |
RxCUI: 2609517 | Iodine (as ethiodised oil) 190 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2609517 | Iodine (as ethiodised oil) 190 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2609518 | Paclitaxel (as albumin bound paclitaxel) 250 mg powder for dispersion for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609518 | Paclitaxel (as albumin bound paclitaxel) 250 mg powder for dispersion for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609519 | Paired box protein Pax-5 | Designated preferred name (PT) | NO | |
RxCUI: 2609519 | Paired box protein Pax-5 | Full form of descriptor (FN) | NO | |
RxCUI: 2609520 | Patisiran (as patisiran sodium) 2 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
RxCUI: 2609520 | Patisiran (as patisiran sodium) 2 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
RxCUI: 2609521 | Colfosceril palmitate 108 mg powder for suspension for endotracheopulmonary instillation vial | Designated preferred name (PT) | NO | |
RxCUI: 2609521 | Colfosceril palmitate 108 mg powder for suspension for endotracheopulmonary instillation vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609522 | Drug-coated coronary artery stent | Designated preferred name (PT) | NO | |
RxCUI: 2609522 | Drug-coated coronary artery stent | Full form of descriptor (FN) | NO | |
RxCUI: 2609523 | Erythromycin (as erythromycin lactobionate) 1 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609523 | Erythromycin (as erythromycin lactobionate) 1 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609526 | Phenoxymethylpenicillin calcium 50 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609526 | Phenoxymethylpenicillin calcium 50 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609526 | Phenoxymethylpenicillin calcium 50 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609527 | Riboflavin sodium phosphate dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609527 | Riboflavin sodium phosphate dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609528 | Rosuvastatin zinc | Designated preferred name (PT) | NO | |
RxCUI: 2609528 | Rosuvastatin zinc | Full form of descriptor (FN) | NO | |
RxCUI: 2609529 | Micropolyspora faeni antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609529 | Micropolyspora faeni antigen | Designated preferred name (PT) | NO | |
RxCUI: 2609529 | Micropolyspora faeni antigen | Full form of descriptor (FN) | NO | |
RxCUI: 2609530 | Zinc finger protein 797 | Designated preferred name (PT) | NO | |
RxCUI: 2609530 | Zinc finger protein 797 | Full form of descriptor (FN) | NO | |
RxCUI: 2609530 | Zinc finger protein 797 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609530 | Zinc finger protein 797 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609531 | Povidone iodine 50 mg/g cutaneous ointment | Designated preferred name (PT) | NO | |
RxCUI: 2609531 | Povidone iodine 50 mg/g cutaneous ointment | Full form of descriptor (FN) | NO | |
RxCUI: 2609532 | Ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609532 | Ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609533 | Ciprofloxacin (as ciprofloxacin hydrochloride) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609533 | Ciprofloxacin (as ciprofloxacin hydrochloride) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609534 | 5-aminolevulinic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609534 | 5-aminolevulinic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609535 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609535 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609535 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609536 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609536 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609536 | Aceclofenac- and chlorzoxazone- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609537 | Cetirizine- and paracetamol- and phenylephrine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609537 | Cetirizine- and paracetamol- and phenylephrine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609537 | Cetirizine- and paracetamol- and phenylephrine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609538 | Cetirizine- and paracetamol- and phenylephrine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609538 | Cetirizine- and paracetamol- and phenylephrine-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609538 | Cetirizine- and paracetamol- and phenylephrine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609539 | Chlorzoxazone- and diclofenac- and paracetamol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609539 | Chlorzoxazone- and diclofenac- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609539 | Chlorzoxazone- and diclofenac- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609540 | Chlorzoxazone- and diclofenac- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609540 | Chlorzoxazone- and diclofenac- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609540 | Chlorzoxazone- and diclofenac- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609541 | Diclofenac- and paracetamol- and serrapeptase-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609541 | Diclofenac- and paracetamol- and serrapeptase-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609541 | Diclofenac- and paracetamol- and serrapeptase-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609542 | Diclofenac- and paracetamol- and serrapeptase-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609542 | Diclofenac- and paracetamol- and serrapeptase-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609542 | Diclofenac- and paracetamol- and serrapeptase-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609543 | Mefenamic acid- and paracetamol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609543 | Mefenamic acid- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609543 | Mefenamic acid- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609544 | Mefenamic acid- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609544 | Mefenamic acid- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609544 | Mefenamic acid- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609545 | Acetylcysteine- and taurine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609545 | Acetylcysteine- and taurine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609546 | Acetylcysteine- and taurine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609546 | Acetylcysteine- and taurine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609547 | Salbutamol- and theophylline-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609547 | Salbutamol- and theophylline-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609547 | Salbutamol- and theophylline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609548 | Salbutamol- and theophylline-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609548 | Salbutamol- and theophylline-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609548 | Salbutamol- and theophylline-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609549 | Alprazolam- and propranolol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609549 | Alprazolam- and propranolol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609550 | Alprazolam- and propranolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609550 | Alprazolam- and propranolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609551 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609551 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609551 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609552 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609552 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609552 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609553 | Ambroxol- and guaifenesin- and terbutaline-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609553 | Ambroxol- and guaifenesin- and terbutaline-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609554 | Ambroxol- and guaifenesin- and terbutaline-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609554 | Ambroxol- and guaifenesin- and terbutaline-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609555 | Amikacin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609555 | Amikacin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609556 | Amlodipine- and atenolol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609556 | Amlodipine- and atenolol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609557 | Amlodipine- and atenolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609557 | Amlodipine- and atenolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609558 | Amlodipine- and metoprolol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609558 | Amlodipine- and metoprolol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609559 | Amlodipine- and metoprolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609559 | Amlodipine- and metoprolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609560 | Artenimol- and piperaquine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609560 | Artenimol- and piperaquine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609596 | testosterone undecanoate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2609597 | testosterone undecanoate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609597 | testosterone undecanoate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2609598 | Kyzatrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2609599 | testosterone undecanoate 100 MG [Kyzatrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609600 | Kyzatrex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2609601 | Kyzatrex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2609602 | testosterone Oral Capsule [Kyzatrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2609603 | KYZATREX 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609603 | KYZATREX 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609603 | KYZATREX 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609604 | testosterone undecanoate 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2609605 | testosterone undecanoate 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609605 | testosterone undecanoate 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2609606 | testosterone undecanoate 150 MG [Kyzatrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609607 | KYZATREX 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609607 | KYZATREX 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609607 | KYZATREX 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609608 | testosterone undecanoate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2609609 | testosterone undecanoate 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609609 | testosterone undecanoate 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2609610 | testosterone undecanoate 200 MG [Kyzatrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609611 | KYZATREX 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609611 | KYZATREX 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609611 | KYZATREX 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609612 | Ammonia 35 mg/mL cutaneous emulsion | Designated preferred name (PT) | NO | |
RxCUI: 2609612 | Ammonia 35 mg/mL cutaneous emulsion | Full form of descriptor (FN) | NO | |
RxCUI: 2609613 | Levocloperastine fendizoate 7.08 mg/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609613 | Levocloperastine fendizoate 7.08 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609614 | Fluocortolone acetate | Designated preferred name (PT) | NO | |
RxCUI: 2609614 | Fluocortolone acetate | Full form of descriptor (FN) | NO | |
RxCUI: 2609615 | Preferentially expressed antigen of melanoma | Designated preferred name (PT) | NO | |
RxCUI: 2609615 | Preferentially expressed antigen of melanoma | Full form of descriptor (FN) | NO | |
RxCUI: 2609615 | Preferentially expressed antigen of melanoma | British preferred term (PTGB) | NO | |
RxCUI: 2609615 | Preferentially expressed antigen of melanoma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609616 | Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion | Designated preferred name (PT) | NO | |
RxCUI: 2609616 | Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion | Full form of descriptor (FN) | NO | |
RxCUI: 2609617 | Betamethasone (as betamethasone valerate) 1 mg/g cutaneous foam | Designated preferred name (PT) | NO | |
RxCUI: 2609617 | Betamethasone (as betamethasone valerate) 1 mg/g cutaneous foam | Full form of descriptor (FN) | NO | |
RxCUI: 2609618 | Budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609618 | Budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609619 | Flurbiprofen sodium dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609619 | Flurbiprofen sodium dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609620 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609620 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609621 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609621 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609622 | Methyldopa sesquihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2609622 | Methyldopa sesquihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2609623 | Cefatrizine propylene glycol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609623 | Cefatrizine propylene glycol | Designated preferred name (PT) | NO | |
RxCUI: 2609623 | Cefatrizine propylene glycol | Full form of descriptor (FN) | NO | |
RxCUI: 2609624 | Myb-related protein A | Designated preferred name (PT) | NO | |
RxCUI: 2609624 | Myb-related protein A | Full form of descriptor (FN) | NO | |
RxCUI: 2609625 | Substance with steroid structure and androgen synthesis inhibitor mechanism of action | Designated preferred name (PT) | NO | |
RxCUI: 2609625 | Substance with steroid structure and androgen synthesis inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609625 | Substance with steroid structure and androgen synthesis inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
RxCUI: 2609626 | Substance with salicylamide structure | Designated preferred name (PT) | NO | |
RxCUI: 2609626 | Substance with salicylamide structure | Full form of descriptor (FN) | NO | |
RxCUI: 2609627 | Substance with triazole structure | Designated preferred name (PT) | NO | |
RxCUI: 2609627 | Substance with triazole structure | Full form of descriptor (FN) | NO | |
RxCUI: 2609628 | Flavoprotein subunit of complex II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609628 | Flavoprotein subunit of complex II | Designated preferred name (PT) | NO | |
RxCUI: 2609628 | Flavoprotein subunit of complex II | Full form of descriptor (FN) | NO | |
RxCUI: 2609629 | Iron-sulfur subunit of complex II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609629 | Iron-sulfur subunit of complex II | Designated preferred name (PT) | NO | |
RxCUI: 2609629 | Iron-sulfur subunit of complex II | Full form of descriptor (FN) | NO | |
RxCUI: 2609630 | Artenimol- and piperaquine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609630 | Artenimol- and piperaquine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609631 | Artesunate- and pyronaridine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609631 | Artesunate- and pyronaridine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609632 | Artesunate- and pyronaridine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609632 | Artesunate- and pyronaridine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609633 | Atenolol- and levamlodipine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609633 | Atenolol- and levamlodipine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609634 | Atenolol- and levamlodipine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609634 | Atenolol- and levamlodipine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609635 | Atorvastatin- and clopidogrel-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609635 | Atorvastatin- and clopidogrel-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609636 | Atorvastatin- and clopidogrel-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609636 | Atorvastatin- and clopidogrel-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609637 | Atorvastatin- and fenofibrate-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609637 | Atorvastatin- and fenofibrate-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609638 | Atorvastatin- and fenofibrate-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609638 | Atorvastatin- and fenofibrate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609639 | Bacitracin- and neomycin- and sulfacetamide-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609639 | Bacitracin- and neomycin- and sulfacetamide-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609640 | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609640 | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609641 | Barium sulfate-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609641 | Barium sulfate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609642 | Beclometasone- and levosalbutamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609642 | Beclometasone- and levosalbutamol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609642 | Beclometasone- and levosalbutamol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609643 | Beclometasone- and levosalbutamol-containing product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609643 | Beclometasone- and levosalbutamol-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609643 | Beclometasone- and levosalbutamol-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609644 | Calcium chloride- and potassium chloride- and sodium chloride- and sodium lactate-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609644 | Calcium chloride- and potassium chloride- and sodium chloride- and sodium lactate-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609645 | Calcium chloride- and potassium chloride- and sodium chloride- and sodium lactate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609645 | Calcium chloride- and potassium chloride- and sodium chloride- and sodium lactate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609646 | Carbazochrome-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609646 | Carbazochrome-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609647 | Castor oil- and colophony-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609647 | Castor oil- and colophony-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609648 | Cefoperazone- and sulbactam-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609648 | Cefoperazone- and sulbactam-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609649 | Ceftriaxone- and sulbactam-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609649 | Ceftriaxone- and sulbactam-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609650 | Ceftriaxone- and sulbactam-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609650 | Ceftriaxone- and sulbactam-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609651 | Ceftriaxone- and tazobactam-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609651 | Ceftriaxone- and tazobactam-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609652 | Ceftriaxone- and tazobactam-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609652 | Ceftriaxone- and tazobactam-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609653 | Cefuroxime- and clavulanic acid-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609653 | Cefuroxime- and clavulanic acid-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609654 | Cefuroxime- and clavulanic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609654 | Cefuroxime- and clavulanic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609655 | Ciclesonide- and formoterol- and tiotropium-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609655 | Ciclesonide- and formoterol- and tiotropium-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609656 | Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609656 | Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609659 | Ciprofloxacin- and tinidazole-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609659 | Ciprofloxacin- and tinidazole-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609660 | Ciprofloxacin- and tinidazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609660 | Ciprofloxacin- and tinidazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609661 | Coagulation factor VIII-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609661 | Coagulation factor VIII-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609662 | Dicycloverine- and mefenamic acid-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609662 | Dicycloverine- and mefenamic acid-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609662 | Dicycloverine- and mefenamic acid-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609663 | Dicycloverine- and mefenamic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609663 | Dicycloverine- and mefenamic acid-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609663 | Dicycloverine- and mefenamic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609664 | Dicycloverine- and simeticone-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609664 | Dicycloverine- and simeticone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609664 | Dicycloverine- and simeticone-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609665 | Dicycloverine- and simeticone-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609665 | Dicycloverine- and simeticone-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609665 | Dicycloverine- and simeticone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609666 | Dolutegravir- and lamivudine- and tenofovir-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609666 | Dolutegravir- and lamivudine- and tenofovir-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609667 | Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609667 | Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609668 | Drotaverine- and mefenamic acid-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609668 | Drotaverine- and mefenamic acid-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609669 | Drotaverine- and mefenamic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609669 | Drotaverine- and mefenamic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609670 | Duloxetine- and mecobalamin-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609670 | Duloxetine- and mecobalamin-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609671 | Duloxetine- and mecobalamin-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609671 | Duloxetine- and mecobalamin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609672 | Ethiodised oil-containing product in oral dose form | British preferred term (PTGB) | NO | |
RxCUI: 2609672 | Ethiodised oil-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609672 | Ethiodised oil-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609673 | Ethiodised oil-containing product in parenteral dose form | British preferred term (PTGB) | NO | |
RxCUI: 2609673 | Ethiodised oil-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609673 | Ethiodised oil-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609674 | Etoricoxib- and thiocolchicoside-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609674 | Etoricoxib- and thiocolchicoside-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609675 | Etoricoxib- and thiocolchicoside-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609675 | Etoricoxib- and thiocolchicoside-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609676 | Fluticasone- and formoterol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609676 | Fluticasone- and formoterol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609677 | Fluticasone- and formoterol-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609677 | Fluticasone- and formoterol-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609678 | Gabapentin- and mecobalamin-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609678 | Gabapentin- and mecobalamin-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609679 | Gabapentin- and mecobalamin-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609679 | Gabapentin- and mecobalamin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609680 | Gabapentin- and nortriptyline-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609680 | Gabapentin- and nortriptyline-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609681 | Gabapentin- and nortriptyline-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609681 | Gabapentin- and nortriptyline-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609682 | Gliclazide- and metformin-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609682 | Gliclazide- and metformin-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609683 | Gliclazide- and metformin-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609683 | Gliclazide- and metformin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609684 | Glucose- and potassium chloride- and sodium bicarbonate- and sodium chloride-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609684 | Glucose- and potassium chloride- and sodium bicarbonate- and sodium chloride-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609685 | Glucose- and potassium chloride- and sodium bicarbonate- and sodium chloride-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609685 | Glucose- and potassium chloride- and sodium bicarbonate- and sodium chloride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609686 | Glucose- and potassium chloride- and sodium chloride- and sodium citrate-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609686 | Glucose- and potassium chloride- and sodium chloride- and sodium citrate-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609687 | Glucose- and potassium chloride- and sodium chloride- and sodium citrate-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609687 | Glucose- and potassium chloride- and sodium chloride- and sodium citrate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609688 | Haemophilus influenzae type b antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2609688 | Haemophilus influenzae type b antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2609689 | Hydrochlorothiazide- and levamlodipine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609689 | Hydrochlorothiazide- and levamlodipine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609690 | Hydrochlorothiazide- and levamlodipine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609690 | Hydrochlorothiazide- and levamlodipine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609691 | Hydrochlorothiazide- and nebivolol-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609691 | Hydrochlorothiazide- and nebivolol-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609692 | Hydrochlorothiazide- and nebivolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609692 | Hydrochlorothiazide- and nebivolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609693 | Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609693 | Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609694 | Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609694 | Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609696 | Isosorbide mononitrate-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609696 | Isosorbide mononitrate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609697 | Itopride- and pantoprazole-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609697 | Itopride- and pantoprazole-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609698 | Itopride- and pantoprazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609698 | Itopride- and pantoprazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609699 | Levocetirizine- and montelukast-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609699 | Levocetirizine- and montelukast-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 26097 | Hemoglobin F1 | British preferred term (PTGB) | NO | |
RxCUI: 26097 | Hemoglobin F1 | Designated preferred name (PT) | NO | |
RxCUI: 26097 | Hemoglobin F1 | Full form of descriptor (FN) | NO | |
RxCUI: 26097 | Hemoglobin F1 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 26097 | Hemoglobin F1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609700 | Levocetirizine- and montelukast-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609700 | Levocetirizine- and montelukast-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609701 | Levocloperastine-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609701 | Levocloperastine-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609702 | Levocloperastine-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609702 | Levocloperastine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609703 | Levomefolic acid- and mecobalamin- and pyridoxal-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609703 | Levomefolic acid- and mecobalamin- and pyridoxal-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609704 | Levomefolic acid- and mecobalamin- and pyridoxal-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609704 | Levomefolic acid- and mecobalamin- and pyridoxal-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609705 | Levosulpiride- and rabeprazole-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609705 | Levosulpiride- and rabeprazole-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609706 | Levosulpiride- and rabeprazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609706 | Levosulpiride- and rabeprazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609707 | Mecobalamin- and piracetam-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609707 | Mecobalamin- and piracetam-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609708 | Mecobalamin- and piracetam-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609708 | Mecobalamin- and piracetam-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609709 | Metformin- and voglibose-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609709 | Metformin- and voglibose-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609710 | Metformin- and voglibose-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609710 | Metformin- and voglibose-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609711 | Metoprolol- and telmisartan-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2609711 | Metoprolol- and telmisartan-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2609712 | Metoprolol- and telmisartan-containing product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609712 | Metoprolol- and telmisartan-containing product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609713 | Benzathine benzylpenicillin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609713 | Benzathine benzylpenicillin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609713 | Benzathine benzylpenicillin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609714 | Procaine benzylpenicillin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2609714 | Procaine benzylpenicillin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609714 | Procaine benzylpenicillin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2609715 | Product containing seratrodast (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2609715 | Product containing seratrodast (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2609716 | Product containing seratrodast in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2609716 | Product containing seratrodast in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2609717 | Product containing silver in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2609717 | Product containing silver in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2609719 | Dicycloverine hydrochloride 10 mg/mL and simeticone 40 mg/mL oral drops | Designated preferred name (PT) | NO | |
RxCUI: 2609719 | Dicycloverine hydrochloride 10 mg/mL and simeticone 40 mg/mL oral drops | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609719 | Dicycloverine hydrochloride 10 mg/mL and simeticone 40 mg/mL oral drops | Full form of descriptor (FN) | NO | |
RxCUI: 2609720 | Hydrocortisone sodium phosphate 3.35 mg/mL eye drops | Designated preferred name (PT) | NO | |
RxCUI: 2609720 | Hydrocortisone sodium phosphate 3.35 mg/mL eye drops | Full form of descriptor (FN) | NO | |
RxCUI: 2609721 | Hydroxocobalamin 2.5 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
RxCUI: 2609721 | Hydroxocobalamin 2.5 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609722 | Ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609722 | Ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609722 | Ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609723 | OCT-binding factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609723 | OCT-binding factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609723 | OCT-binding factor 1 | Designated preferred name (PT) | NO | |
RxCUI: 2609723 | OCT-binding factor 1 | Full form of descriptor (FN) | NO | |
RxCUI: 2609724 | Octamer-binding transcription factor 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609724 | Octamer-binding transcription factor 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609724 | Octamer-binding transcription factor 2 | Designated preferred name (PT) | NO | |
RxCUI: 2609724 | Octamer-binding transcription factor 2 | Full form of descriptor (FN) | NO | |
RxCUI: 2609728 | Coal tar 50 mg/g cutaneous emulsion | Designated preferred name (PT) | NO | |
RxCUI: 2609728 | Coal tar 50 mg/g cutaneous emulsion | Full form of descriptor (FN) | NO | |
RxCUI: 2609729 | Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Designated preferred name (PT) | NO | |
RxCUI: 2609729 | Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Full form of descriptor (FN) | NO | |
RxCUI: 2609730 | Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609730 | Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609730 | Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609731 | Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
RxCUI: 2609731 | Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609731 | Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2609731 | Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609731 | Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609732 | Beef derivative | Designated preferred name (PT) | NO | |
RxCUI: 2609732 | Beef derivative | Full form of descriptor (FN) | NO | |
RxCUI: 2609733 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension | Designated preferred name (PT) | NO | |
RxCUI: 2609733 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension | British preferred term (PTGB) | NO | |
RxCUI: 2609733 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2609734 | Magistral preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609734 | Magistral preparation | Designated preferred name (PT) | NO | |
RxCUI: 2609734 | Magistral preparation | Full form of descriptor (FN) | NO | |
RxCUI: 2609734 | Magistral preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609735 | Fluorescein sodium 10 mg/mL eye drops | Designated preferred name (PT) | NO | |
RxCUI: 2609735 | Fluorescein sodium 10 mg/mL eye drops | Full form of descriptor (FN) | NO | |
RxCUI: 2609736 | Mecobalamin 500 microgram/mL and piracetam 500 mg/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2609736 | Mecobalamin 500 microgram/mL and piracetam 500 mg/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609737 | Blood gas | Designated preferred name (PT) | NO | |
RxCUI: 2609737 | Blood gas | Full form of descriptor (FN) | NO | |
RxCUI: 2609738 | Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurised suspension for inhalation | British preferred term (PTGB) | NO | |
RxCUI: 2609738 | Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurised suspension for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609738 | Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurised suspension for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609739 | Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
RxCUI: 2609739 | Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
RxCUI: 2609760 | Calamine 150 mg/mL and zinc oxide 50 mg/mL cutaneous lotion | Designated preferred name (PT) | NO | |
RxCUI: 2609760 | Calamine 150 mg/mL and zinc oxide 50 mg/mL cutaneous lotion | Full form of descriptor (FN) | NO | |
RxCUI: 2609761 | camphor / capsaicin / menthol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2609762 | camphor 11 % / capsaicin 0.1 % / menthol 16 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609762 | camphor 11 % / capsaicin 0.1 % / menthol 16 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609762 | camphor 11 % / capsaicin 0.1 % / menthol 16 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609763 | petrolatum 0.443 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2609764 | petrolatum 44.3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609764 | petrolatum 44.3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609764 | petrolatum 44.3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609764 | petrolatum 44.3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609765 | PCA-1 - B-cell marker | Designated preferred name (PT) | NO | |
RxCUI: 2609765 | PCA-1 - B-cell marker | Full form of descriptor (FN) | NO | |
RxCUI: 2609765 | PCA-1 - B-cell marker | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609766 | Budgerigar droppings | Designated preferred name (PT) | NO | |
RxCUI: 2609766 | Budgerigar droppings | Full form of descriptor (FN) | NO | |
RxCUI: 2609767 | Bos taurus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609767 | Bos taurus protein | Full form of descriptor (FN) | NO | |
RxCUI: 2609767 | Bos taurus protein | Designated preferred name (PT) | NO | |
RxCUI: 2609767 | Bos taurus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609769 | Glutamate (13-N) | Designated preferred name (PT) | NO | |
RxCUI: 2609769 | Glutamate (13-N) | Full form of descriptor (FN) | NO | |
RxCUI: 2609770 | Glycogen limit dextrin | Designated preferred name (PT) | NO | |
RxCUI: 2609770 | Glycogen limit dextrin | Full form of descriptor (FN) | NO | |
RxCUI: 2609771 | Midazolam (as midazolam hydrochloride) 10 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
RxCUI: 2609771 | Midazolam (as midazolam hydrochloride) 10 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609772 | Organic cation transporter 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609772 | Organic cation transporter 3 | Designated preferred name (PT) | NO | |
RxCUI: 2609772 | Organic cation transporter 3 | Full form of descriptor (FN) | NO | |
RxCUI: 2609773 | Proto-oncogene c-Myb | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609773 | Proto-oncogene c-Myb | Designated preferred name (PT) | NO | |
RxCUI: 2609773 | Proto-oncogene c-Myb | Full form of descriptor (FN) | NO | |
RxCUI: 2609775 | Gemcitabine (as gemcitabine hydrochloride) 40 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
RxCUI: 2609775 | Gemcitabine (as gemcitabine hydrochloride) 40 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
RxCUI: 2609777 | HML-1 | Designated preferred name (PT) | NO | |
RxCUI: 2609777 | HML-1 | Full form of descriptor (FN) | NO | |
RxCUI: 2609779 | Midazolam (as midazolam maleate) 10 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
RxCUI: 2609779 | Midazolam (as midazolam maleate) 10 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
RxCUI: 2609780 | S-100 - Neuronal cell marker | Designated preferred name (PT) | NO | |
RxCUI: 2609780 | S-100 - Neuronal cell marker | Full form of descriptor (FN) | NO | |
RxCUI: 2609780 | S-100 - Neuronal cell marker | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609782 | Product containing precisely silver nanoparticle 20 microgram/1 gram conventional release cutaneous gel (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609782 | Product containing precisely silver nanoparticle 20 microgram/1 gram conventional release cutaneous gel (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609783 | Surgical spirit | Designated preferred name (PT) | NO | |
RxCUI: 2609783 | Surgical spirit | Full form of descriptor (FN) | NO | |
RxCUI: 260980 | 12 HR guaifenesin 1200 MG Extended Release Oral Tablet [Liquidbid 1200] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 260980 | 12 HR guaifenesin 1200 MG Extended Release Oral Tablet [Liquidbid 1200] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 260980 | 12 HR guaifenesin 1200 MG Extended Release Oral Tablet [Liquidbid 1200] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 260980 | 12 HR guaifenesin 1200 MG Extended Release Oral Tablet [Liquidbid 1200] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609844 | ethylcellulose aqueous dispersion type A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2609845 | ketoconazole Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2609846 | ketoconazole Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2609847 | ketoconazole 0.2 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609847 | ketoconazole 0.2 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609847 | ketoconazole 0.2 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609848 | dimethicone 1 % / zinc oxide 15 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609848 | dimethicone 1 % / zinc oxide 15 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609848 | dimethicone 1 % / zinc oxide 15 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609848 | dimethicone 1 % / zinc oxide 15 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609849 | Benzathine benzylpenicillin 1.2 million unit powder for suspension for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609849 | Benzathine benzylpenicillin 1.2 million unit powder for suspension for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2609849 | Benzathine benzylpenicillin 1.2 million unit powder for suspension for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609850 | Benzathine benzylpenicillin 2.4 million unit powder for suspension for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609850 | Benzathine benzylpenicillin 2.4 million unit powder for suspension for injection vial | Designated preferred name (PT) | NO | |
RxCUI: 2609850 | Benzathine benzylpenicillin 2.4 million unit powder for suspension for injection vial | Full form of descriptor (FN) | NO | |
RxCUI: 2609898 | firocoxib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2609899 | firocoxib 57 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609899 | firocoxib 57 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2609900 | Nymphaea caerulea flower volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2609902 | Icatibant (as icatibant acetate) 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2609902 | Icatibant (as icatibant acetate) 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2609903 | Inotersen (as inotersen sodium) 189.333 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2609903 | Inotersen (as inotersen sodium) 189.333 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2609904 | Insulin lispro 200 unit/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2609904 | Insulin lispro 200 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2609905 | Lanreotide (as lanreotide acetate) 240 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2609905 | Lanreotide (as lanreotide acetate) 240 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2609906 | Liraglutide 6 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 2609906 | Liraglutide 6 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 2609907 | Product containing precisely sodium nitroprusside 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609907 | Product containing precisely sodium nitroprusside 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609908 | Product containing precisely spectinomycin (as spectinomycin hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2609908 | Product containing precisely spectinomycin (as spectinomycin hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2609924 | diphenhydramine hydrochloride 50 MG [Sleep-Eze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2609924 | diphenhydramine hydrochloride 50 MG [Sleep-Eze] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2609925 | diphenhydramine Oral Capsule [Sleep-Eze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2609925 | diphenhydramine Oral Capsule [Sleep-Eze] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2609926 | Sleep-Eze 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2609926 | Sleep-Eze 50 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2609926 | Sleep-Eze 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2609926 | Sleep-Eze 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2609928 | Regener-Eyes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2609929 | glycerin 5 MG/ML [Regener-Eyes] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2609930 | Regener-Eyes Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2609931 | glycerin Ophthalmic Solution [Regener-Eyes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2609932 | Regener-Eyes 0.5 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2609932 | Regener-Eyes 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2609932 | Regener-Eyes 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609932 | Regener-Eyes 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2609933 | Siponimod fumaric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |